Fibromyalgia Community Fibromyalgia AWARE Magazine Resources Research About National Fibromyalgia Association Members

 

Research
Research Abstracts
Listing of Current Clinical Trials
Glossary of Terms and Definitions
Research overview
Health Providers

Home > Research > Clinical Trials Resource Center

Clinical Trials Resource Center


Therapeutic Areas: Psychiatry/Psychology | Neurology

Schizophrenia and Schizoaffective Disorders Clinical Trials


A listing of Schizophrenia and Schizoaffective Disorders medical research trials actively recruiting patient volunteers. Click on the closest state and city to find more detailed information on a research study in your area.

Alabama

Birmingham : Pfizer Investigational Site

A clinical trial to evaluate treatments using PF-02545920 and Placebo for patients with Schizophrenia

Dothan : Harmonex Neuroscience Research

Patients are needed to participate in a clinical research study of Lurasidone 20, 40, 60, 80 mg, flexibly dosed to evaluate Schizophrenia or Austism

Dothan : Harmonex Neuroscience Research

Patients are needed to participate in a clinical research study to evaluate Schizophrenia

Arizona

Tucson :

A clinical research study of Brexpiprazole for the treatment of Major Depressive Disorder or Anxiety

Arkansas

Little Rock : Research Site

20110165: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms

Little Rock : Alkermes Investigational Site

A clinical trial to evaluate treatments for patients with Schizophrenia

Little Rock : Pfizer Investigational Site

A clinical trial to evaluate treatments using PF-02545920 and Placebo for patients with Schizophrenia

Little Rock :

A Phase 3 clinical study for patients with Schizophrenia or Impaired Cognition

Little Rock : Alkermes Investigational Site

Patients are needed to participate in a clinical research study evaluating ALKS 9072, Low and ALKS 9072, High for the treatment of Schizophrenia

Little Rock :

Patients are needed to participate in a clinical research study of EVP-6124 to evaluate Schizophrenia or Impaired Cognition

Springdale : Research Site

20110165: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms

California

Culver City : California Clinical Trials Medical Group, Inc.

Do you have schizophrenia or schizoaffective disorder?

Glendale : California Clinical Trials Medical Group, Inc.

An inpatient study comparing different types of the same study medication administered to subjects with schisophrenia, schizoaffective disorder, or schisophreniform disorder.

Glendale : CNS Healthcare

Schizophrenia and Schizoaffective Disorders Study

Pasadena : Pasadena Research Institute

Seeking Volunteers Diagnosed With Schizophrenia

Sherman Oaks : Schuster Medical Research Institute

Schizophrenia Inpatient/Outpatient Study

Sherman Oaks : Schuster Medical Research Institute

Schizophrenia Outpatient Clinical Research Study

Anaheim : Research Site

20101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms

Anaheim :

A clinical trial seeking patients for a research study for the treatment of Schizophrenia or Impaired Cognition

Anaheim : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Iloperidone and Placebo for the treatment of Schizophrenia

Anaheim :

Patients are needed to participate in a clinical research study of EVP-6124 to evaluate Schizophrenia or Impaired Cognition

Bellflower :

A clinical trial seeking patients for a research study for the treatment of Schizophrenia or Impaired Cognition

Bellflower :

Patients are needed to participate in a clinical research study of EVP-6124 to evaluate Schizophrenia or Impaired Cognition

Cerritos : Research Site

20101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms

Cerritos :

A clinical trial to evaluate treatments using Aripiprazole and Ingestible Event Marker (IEM) for patients with Bipolar 1 Disorder, Schizophrenia, Mental Disorder or Nervous System Diseases

Cerritos :

A clinical trial to evaluate treatments using Brexpiprazole and Placebo for patients with Acute Schizophrenia

Cerritos :

A clinical trial to evaluate treatments using Brexpiprazole for patients with Schizophrenia

Cerritos : Pfizer Investigational Site

A clinical trial to evaluate treatments using PF-02545920 and Placebo for patients with Schizophrenia

Cerritos :

A Phase 3 clinical study for patients with MDD

Cerritos :

A Phase 3 clinical study for patients with Schizophrenia or Impaired Cognition

Cerritos :

Patients are needed to participate in a clinical research study of EVP-6124 to evaluate Schizophrenia or Impaired Cognition

Chino :

A Phase 3 clinical study for patients with Schizophrenia or Impaired Cognition

Chino :

Patients are needed to participate in a clinical research study of EVP-6124 to evaluate Schizophrenia or Impaired Cognition

Chula Vista :

A clinical trial to evaluate treatments using Brexpiprazole for patients with Schizophrenia

Costa Mesa :

A clinical trial seeking patients for a research study for the treatment of Schizophrenia or Impaired Cognition

Costa Mesa : Call for Information (Investigational Site 2003)

A clinical trial to evaluate treatments using Asenapine, Placebo Asenapine, Olanzapine and Placebo Olanzapine for patients with Schizophrenia

Costa Mesa :

A clinical trial to evaluate treatments using Brexpiprazole for patients with Schizophrenia

Costa Mesa :

A Phase 3 clinical study for patients with MDD

Costa Mesa :

A Phase 3 clinical study for patients with Schizophrenia or Impaired Cognition

Costa Mesa : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Iloperidone and Placebo for the treatment of Schizophrenia

Costa Mesa :

Patients are needed to participate in a clinical research study of EVP-6124 to evaluate Schizophrenia or Impaired Cognition

Culver City : Research Site

20101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms

Culver City :

A clinical trial seeking patients for a research study for the treatment of Schizophrenia or Impaired Cognition

Culver City : Alkermes Investigational Site

A clinical trial to evaluate treatments for patients with Schizophrenia

Culver City : Pfizer Investigational Site

A clinical trial to evaluate treatments using PF-02545920 and Placebo for patients with Schizophrenia

Culver City :

Patients are needed to participate in a clinical research study of EVP-6124 to evaluate Schizophrenia or Impaired Cognition

Culver City : ProScience Research Group

Patients are needed to participate in a clinical research study to evaluate Schizophrenia

Downey :

A clinical trial seeking patients for a research study for the treatment of Schizophrenia or Impaired Cognition

Downey :

Patients are needed to participate in a clinical research study of EVP-6124 to evaluate Schizophrenia or Impaired Cognition

Downey : Diligent Clinical Trials, Inc

Patients are needed to participate in a clinical research study to evaluate Schizophrenia

Escondido :

A clinical trial seeking patients for a research study for the treatment of Schizophrenia or Impaired Cognition

Escondido : Alkermes Investigational Site

A clinical trial to evaluate treatments for patients with Schizophrenia

Escondido : Pfizer Investigational Site

A clinical trial to evaluate treatments using PF-02545920 and Placebo for patients with Schizophrenia

Escondido : US009

A Phase 3 clinical study for patients with Schizophrenia

Escondido : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Iloperidone and Placebo for the treatment of Schizophrenia

Escondido :

Patients are needed to participate in a clinical research study of EVP-6124 to evaluate Schizophrenia or Impaired Cognition

Escondido : US009

Patients are needed to participate in a clinical research study of Placebo, Brexpiprazole and Quetiapine extended release to evaluate Schizophrenia

Garden Grove : Research Site

20101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms

Garden Grove :

A clinical research study of Brexpiprazole for the treatment of Major Depressive Disorder or Anxiety

Garden Grove : Alkermes Investigational Site

A clinical trial to evaluate treatments for patients with Schizophrenia

Garden Grove : Novartis Investigative Site

A clinical trial to evaluate treatments using AQW051 and Placebo for patients with Schizophrenia

Garden Grove : Call for Information (Investigational Site 2026)

A clinical trial to evaluate treatments using Asenapine, Placebo Asenapine, Olanzapine and Placebo Olanzapine for patients with Schizophrenia

Garden Grove :

A clinical trial to evaluate treatments using Brexpiprazole and Placebo for patients with Acute Schizophrenia

Garden Grove : Pfizer Investigational Site

A clinical trial to evaluate treatments using PF-02545920 and Placebo for patients with Schizophrenia

Garden Grove :

A Phase 3 clinical study for patients with Schizophrenia or Impaired Cognition

Garden Grove : Alkermes Investigational Site

Patients are needed to participate in a clinical research study evaluating ALKS 9072, Low and ALKS 9072, High for the treatment of Schizophrenia

Garden Grove :

Patients are needed to participate in a clinical research study of EVP-6124 to evaluate Schizophrenia or Impaired Cognition

Garden Grove : Collaborative Neuroscience Network, LLC

Patients are needed to participate in a clinical research study to evaluate Schizophrenia

Glendale :

A clinical trial seeking patients for a research study for the treatment of Schizophrenia

Glendale :

A clinical trial seeking patients for a research study for the treatment of Schizophrenia

Glendale :

A clinical trial seeking patients for a research study for the treatment of Schizophrenia

Glendale : Novartis Investigative Site

A clinical trial to evaluate treatments using AQW051 and Placebo for patients with Schizophrenia

Glendale :

A Phase 3 clinical study for patients with MDD

Glendale :

A Phase 3 clinical study for patients with Schizophrenia or Impaired Cognition

Glendale :

Patients are needed to participate in a clinical research study of EVP-6124 to evaluate Schizophrenia or Impaired Cognition

Glendale : California Clinical Trials Medical Group

Patients are needed to participate in a clinical research study of SEP-363856 and Placebo to evaluate Schizophrenia

Granada Hills :

Patients are needed to participate in a clinical research study for the treatment of Schizophrenia

Irvine : UC Irvine

A Phase 4 clinical study for patients with Schizophrenia

Long Beach : Research Site

20110165: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms

Long Beach : Collaborative Neuroscience Network-Clinical Pharmacology Unit

A clinical research study of NW-3509a for the treatment of Acute Schizophrenia

Long Beach :

A clinical trial to evaluate treatments using Brexpiprazole for patients with Schizophrenia

Long Beach :

Patients are needed to participate in a clinical research study evaluating OMS643762 and Placebo for the treatment of Schizophrenia

Long Beach : Collaborative Neuroscience Network, LLC

Patients are needed to participate in a clinical research study of SEP-363856 and Placebo to evaluate Schizophrenia

Los Angeles : Research Site

20101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms

Los Angeles :

A clinical trial seeking patients for a research study for the treatment of Schizophrenia or Impaired Cognition

Los Angeles : Veteran's Administration of Greater Los Angeles

A clinical trial to evaluate treatments using Eltoprazine and Placebo for patients with Cognitive Impairment or Schizophrenia

Los Angeles : UCLA Semel Institute for Neuroscience and Human Behavior

A Phase 4 clinical study for patients with Schizophrenia (Recent-onset)

Los Angeles : US002

Patients are needed to participate in a clinical research study evaluating Aripiprazole and aripiprazole once-monthly and Paliperidone and paliperidone palmitate for the treatment of Schizophrenia

Los Angeles :

Patients are needed to participate in a clinical research study for the treatment of Schizophrenia

Los Angeles :

Patients are needed to participate in a clinical research study of EVP-6124 to evaluate Schizophrenia or Impaired Cognition

Mesa :

Patients are needed to participate in a clinical research study of EVP-6124 to evaluate Schizophrenia or Impaired Cognition

National City : Alkermes Investigational Site

A clinical trial to evaluate treatments for patients with Schizophrenia

National City : Novartis Investigative Site

A clinical trial to evaluate treatments using AQW051 and Placebo for patients with Schizophrenia

Norwalk : Research Site

20101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms

Norwalk :

A Phase 3 clinical study for patients with Schizophrenia or Impaired Cognition

Oakland : Research Site

20110165: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms

Oakland : Alkermes Investigational Site

A clinical trial to evaluate treatments for patients with Schizophrenia

Oakland : Novartis Investigative Site

A clinical trial to evaluate treatments using AQW051 and Placebo for patients with Schizophrenia

Oakland :

A clinical trial to evaluate treatments using Brexpiprazole for patients with Schizophrenia

Oakland : Pfizer Investigational Site

A clinical trial to evaluate treatments using PF-02545920 and Placebo for patients with Schizophrenia

Oakland :

A Phase 3 clinical study for patients with Schizophrenia or Impaired Cognition

Oakland :

Patients are needed to participate in a clinical research study of EVP-6124 to evaluate Schizophrenia or Impaired Cognition

Oakland Park :

A Phase 3 clinical study for patients with Schizophrenia or Impaired Cognition

Oceanside :

A clinical research study of Brexpiprazole for the treatment of Major Depressive Disorder or Anxiety

Oceanside :

A clinical trial seeking patients for a research study for the treatment of Schizophrenia or Impaired Cognition

Oceanside : Alkermes Investigational Site

A clinical trial to evaluate treatments for patients with Schizophrenia

Oceanside : Call for Information (Investigational Site 2011)

A clinical trial to evaluate treatments using Asenapine, Placebo Asenapine, Olanzapine and Placebo Olanzapine for patients with Schizophrenia

Oceanside :

A clinical trial to evaluate treatments using Brexpiprazole for patients with Schizophrenia

Oceanside : Pfizer Investigational Site

A clinical trial to evaluate treatments using PF-02545920 and Placebo for patients with Schizophrenia

Oceanside :

A Phase 3 clinical study for patients with Schizophrenia or Impaired Cognition

Oceanside : Alkermes Investigational Site

Patients are needed to participate in a clinical research study evaluating ALKS 9072, Low and ALKS 9072, High for the treatment of Schizophrenia

Oceanside : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Iloperidone and Placebo for the treatment of Schizophrenia

Oceanside :

Patients are needed to participate in a clinical research study of EVP-6124 to evaluate Schizophrenia or Impaired Cognition

Orange : Research Site

20110165: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms

Orange :

A clinical trial seeking patients for a research study for the treatment of Schizophrenia or Impaired Cognition

Orange : Alkermes Investigational Site

A clinical trial to evaluate treatments for patients with Schizophrenia

Orange : Pfizer Investigational Site

A clinical trial to evaluate treatments using PF-02545920 and Placebo for patients with Schizophrenia

Orange :

A Phase 3 clinical study for patients with MDD

Orange :

Patients are needed to participate in a clinical research study of EVP-6124 to evaluate Schizophrenia or Impaired Cognition

Orange : Neuropsychiatric Research Center of Orange County

Patients are needed to participate in a clinical research study of LY03004 to evaluate Schizophrenia or Schizoaffective Disorder

Orange : Neuropsychiatric Research Center of Orange County

Patients are needed to participate in a clinical research study to evaluate Schizophrenia

Palo Alto : Palo Alto Veteran's Affairs Medical Center

A Phase 2 clinical study for patients with Schizophrenia

Paramount : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Iloperidone and Placebo for the treatment of Schizophrenia

Pico Rivera : Alkermes Investigational Site

A clinical trial to evaluate treatments for patients with Schizophrenia

Pico Rivera : Novartis Investigative Site

A clinical trial to evaluate treatments using AQW051 and Placebo for patients with Schizophrenia

Pico Rivera : Call for Information (Investigational Site 2015)

A clinical trial to evaluate treatments using Asenapine, Placebo Asenapine, Olanzapine and Placebo Olanzapine for patients with Schizophrenia

Pico Rivera :

A clinical trial to evaluate treatments using Brexpiprazole for patients with Schizophrenia

Pico Rivera : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Iloperidone and Placebo for the treatment of Schizophrenia

Riverside :

A clinical trial to evaluate treatments using Brexpiprazole for patients with Schizophrenia

Riverside : Pfizer Investigational Site

A clinical trial to evaluate treatments using PF-02545920 and Placebo for patients with Schizophrenia

Riverside :

A Phase 3 clinical study for patients with MDD

Riverside :

A Phase 3 clinical study for patients with Schizophrenia or Impaired Cognition

Riverside : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Iloperidone and Placebo for the treatment of Schizophrenia

Riverside :

Patients are needed to participate in a clinical research study of EVP-6124 to evaluate Schizophrenia or Impaired Cognition

San Bernardino : Research Site

20101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms

San Diego : Research Site

20110165: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms

San Diego : University of California San Diego Medical Center

A clinical trial seeking patients for a research study for the treatment of Schizophrenia

San Diego :

A clinical trial seeking patients for a research study for the treatment of Schizophrenia or Impaired Cognition

San Diego : Alkermes Investigational Site

A clinical trial to evaluate treatments for patients with Schizophrenia

San Diego : Novartis Investigative Site

A clinical trial to evaluate treatments using AQW051 and Placebo for patients with Schizophrenia

San Diego : Call for Information (Investigational Site 2006)

A clinical trial to evaluate treatments using Asenapine, Placebo Asenapine, Olanzapine and Placebo Olanzapine for patients with Schizophrenia

San Diego : Call for Information (Investigational Site 2019)

A clinical trial to evaluate treatments using Asenapine, Placebo Asenapine, Olanzapine and Placebo Olanzapine for patients with Schizophrenia

San Diego : Call for Information (Investigational Site 2009)

A clinical trial to evaluate treatments using Asenapine, Placebo Asenapine, Olanzapine and Placebo Olanzapine for patients with Schizophrenia

San Diego : Call for Information (Investigational Site 2023)

A clinical trial to evaluate treatments using Asenapine, Placebo Asenapine, Olanzapine and Placebo Olanzapine for patients with Schizophrenia

San Diego :

A clinical trial to evaluate treatments using Brexpiprazole and Placebo for patients with Acute Schizophrenia

San Diego :

A clinical trial to evaluate treatments using Brexpiprazole and Placebo for patients with Acute Schizophrenia

San Diego :

A clinical trial to evaluate treatments using Brexpiprazole for patients with Schizophrenia

San Diego :

A clinical trial to evaluate treatments using Brexpiprazole for patients with Schizophrenia

San Diego : Pfizer Investigational Site

A clinical trial to evaluate treatments using PF-02545920 and Placebo for patients with Schizophrenia

San Diego : Pfizer Investigational Site

A clinical trial to evaluate treatments using PF-02545920 and Placebo for patients with Schizophrenia

San Diego :

A Phase 3 clinical study for patients with MDD

San Diego :

A Phase 3 clinical study for patients with Schizophrenia or Impaired Cognition

San Diego : Alkermes Investigational Site

Patients are needed to participate in a clinical research study evaluating ALKS 9072, Low and ALKS 9072, High for the treatment of Schizophrenia

San Diego : US006

Patients are needed to participate in a clinical research study evaluating Aripiprazole and aripiprazole once-monthly and Paliperidone and paliperidone palmitate for the treatment of Schizophrenia

San Diego : US006

Patients are needed to participate in a clinical research study evaluating Aripiprazole once-monthly for the treatment of Schizophrenia

San Diego : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Iloperidone and Placebo for the treatment of Schizophrenia

San Diego : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Iloperidone and Placebo for the treatment of Schizophrenia

San Diego : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Iloperidone and Placebo for the treatment of Schizophrenia

San Diego :

Patients are needed to participate in a clinical research study of EVP-6124 to evaluate Schizophrenia or Impaired Cognition

San Francisco : Langley Porter Psychiatric Institute, UCSF

A clinical trial seeking patients for a research study for the treatment of Schizophrenia

San Francisco : San Francisco Veterans Affairs Medical Center

A clinical trial seeking patients for a research study for the treatment of Schizophrenia

San Francisco : Brain Plasticity, Inc.

A Phase 2 clinical study for patients with Schizophrenia

San Gabriel :

A Phase 3 clinical study for patients with Schizophrenia or Impaired Cognition

Santa Ana :

A clinical trial to evaluate treatments using Brexpiprazole for patients with Schizophrenia

Santa Ana :

A Phase 3 clinical study for patients with Schizophrenia or Impaired Cognition

Santa Ana : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Iloperidone and Placebo for the treatment of Schizophrenia

Santa Ana :

Patients are needed to participate in a clinical research study of EVP-6124 to evaluate Schizophrenia or Impaired Cognition

Santa Monica :

Patients are needed to participate in a clinical research study for the treatment of Schizophrenia

Sherman Oaks :

A Phase 3 clinical study for patients with Schizophrenia or Impaired Cognition

Sherman Oaks :

Patients are needed to participate in a clinical research study of EVP-6124 to evaluate Schizophrenia or Impaired Cognition

Temecula :

A clinical research study of Brexpiprazole for the treatment of Major Depressive Disorder or Anxiety

Torrance : Research Site

20101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms

Torrance :

A clinical trial seeking patients for a research study for the treatment of Schizophrenia or Impaired Cognition

Torrance : Alkermes Investigational Site

A clinical trial to evaluate treatments for patients with Schizophrenia

Torrance :

A clinical trial to evaluate treatments using Brexpiprazole for patients with Schizophrenia

Torrance : Pfizer Investigational Site

A clinical trial to evaluate treatments using PF-02545920 and Placebo for patients with Schizophrenia

Torrance :

Patients are needed to participate in a clinical research study of EVP-6124 to evaluate Schizophrenia or Impaired Cognition

Colorado

Denver : Department of Veterans Affairs Eastern Colorado Healthcare System

Aripiprazole for Co-Morbid Schizophrenia and Cocaine Dependence

Connecticut

Cedar Rapids :

Patients are needed to participate in a clinical research study for the treatment of Schizophrenia

Hartford : Pfizer Investigational Site

A clinical trial to evaluate treatments using PF-02545920 and Placebo for patients with Schizophrenia

Hartford : Hartford Hospital

Patients are needed to participate in a clinical research study to evaluate Schizophrenia

New Britain : Alkermes Investigational Site

A clinical trial to evaluate treatments for patients with Schizophrenia

New Haven :

Patients are needed to participate in a clinical research study for the treatment of Schizophrenia

Norwalk :

A clinical trial seeking patients for a research study for the treatment of Schizophrenia or Impaired Cognition

Norwalk :

Patients are needed to participate in a clinical research study of EVP-6124 to evaluate Schizophrenia or Impaired Cognition

Norwich :

A Phase 3 clinical study for patients with MDD

District of Columbia

Washington : Research Site

20101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms

Washington : Alkermes Investigational Site

A clinical trial to evaluate treatments for patients with Schizophrenia

Washington :

A clinical trial to evaluate treatments using Aripiprazole and Ingestible Event Marker (IEM) for patients with Bipolar 1 Disorder, Schizophrenia, Mental Disorder or Nervous System Diseases

Washington : Pfizer Investigational Site

A clinical trial to evaluate treatments using PF-02545920 and Placebo for patients with Schizophrenia

Washington :

A Phase 3 clinical study for patients with Schizophrenia or Impaired Cognition

Washington : Alkermes Investigational Site

Patients are needed to participate in a clinical research study evaluating ALKS 9072, Low and ALKS 9072, High for the treatment of Schizophrenia

Florida

Orange City : Medical Research Group of Central Florida

Schizophrenia Disorder in Adolescents

Bradenton : Alkermes Investigational Site

A clinical trial to evaluate treatments for patients with Schizophrenia

Bradenton : Pfizer Investigational Site

A clinical trial to evaluate treatments using PF-02545920 and Placebo for patients with Schizophrenia

Bradenton :

A Phase 3 clinical study for patients with Schizophrenia or Impaired Cognition

Bradenton : Florida Clinical Research Center, LLC

Patients are needed to participate in a clinical research study to evaluate Schizophrenia

Chicago :

Patients are needed to participate in a clinical research study for the treatment of Schizophrenia

Fort Lauderdale : Alkermes Investigational Site

A clinical trial to evaluate treatments for patients with Schizophrenia

Fort Lauderdale : Call for Information (Investigational Site 2030)

A clinical trial to evaluate treatments using Asenapine, Placebo Asenapine, Olanzapine and Placebo Olanzapine for patients with Schizophrenia

Fort lauderdale :

A clinical trial to evaluate treatments using Brexpiprazole for patients with Schizophrenia

Fort Myers :

A Phase 3 clinical study for patients with MDD

Gainesville :

A clinical research study of Brexpiprazole for the treatment of Major Depressive Disorder or Anxiety

Gainesville : Alkermes Investigational Site

A clinical trial to evaluate treatments for patients with Schizophrenia

Gainesville :

Patients are needed to participate in a clinical research study for the treatment of Schizophrenia

Gainesville :

Patients are needed to participate in a clinical research study for the treatment of Schizophrenia

Gainesville :

Patients are needed to participate in a clinical research study for the treatment of Schizophrenia

Gainesville : Sarkis Clinical Trials - Parent

Patients are needed to participate in a clinical research study to evaluate Schizophrenia

Hialeah :

A Phase 3 clinical study for patients with MDD

Hialeah : Palm Springs Research Institute

Patients are needed to participate in a clinical research study of Lurasidone 20, 40, 60, 80 mg, flexibly dosed to evaluate Schizophrenia or Austism

Jacksonville :

A clinical research study of Brexpiprazole for the treatment of Major Depressive Disorder or Anxiety

Jacksonville :

Patients are needed to participate in a clinical research study for the treatment of Schizophrenia

Jacksonville : Clinical Neuroscience Solutions, Inc.

Patients are needed to participate in a clinical research study of Lurasidone 20, 40, 60, 80 mg, flexibly dosed to evaluate Schizophrenia or Austism

Kissimmee : Research Site

20110165: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms

Kissimmee : Alkermes Investigational Site

A clinical trial to evaluate treatments for patients with Schizophrenia

Lake City :

Patients are needed to participate in a clinical research study for the treatment of Schizophrenia

Lauderhill :

A clinical trial seeking patients for a research study for the treatment of Schizophrenia or Impaired Cognition

Lauderhill : Pfizer Investigational Site

A clinical trial to evaluate treatments using PF-02545920 and Placebo for patients with Schizophrenia

Lauderhill :

Patients are needed to participate in a clinical research study of EVP-6124 to evaluate Schizophrenia or Impaired Cognition

Leesburg : Alkermes Investigational Site

A clinical trial to evaluate treatments for patients with Schizophrenia

Leesburg : Alkermes Investigational Site

Patients are needed to participate in a clinical research study evaluating ALKS 9072, Low and ALKS 9072, High for the treatment of Schizophrenia

Maitland : Call for Information (Investigational Site 2010)

A clinical trial to evaluate treatments using Asenapine, Placebo Asenapine, Olanzapine and Placebo Olanzapine for patients with Schizophrenia

Melbourne :

A Phase 3 clinical study for patients with MDD

Miami :

A clinical research study of Brexpiprazole for the treatment of Major Depressive Disorder or Anxiety

Miami : University of Miami Medical Center

A clinical trial seeking patients for a research study for the treatment of Schizophrenia

Miami :

A clinical trial seeking patients for a research study for the treatment of Schizophrenia or Impaired Cognition

Miami :

A Phase 3 clinical study for patients with Schizophrenia or Impaired Cognition

Miami : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Iloperidone and Placebo for the treatment of Schizophrenia

Miami :

Patients are needed to participate in a clinical research study for the treatment of Schizophrenia

Miami :

Patients are needed to participate in a clinical research study for the treatment of Schizophrenia

Miami :

Patients are needed to participate in a clinical research study of EVP-6124 to evaluate Schizophrenia or Impaired Cognition

Miami Springs :

A Phase 3 clinical study for patients with Schizophrenia or Impaired Cognition

Miramar : Novartis Investigative Site

A clinical trial to evaluate treatments using AQW051 and Placebo for patients with Schizophrenia

North Miami : Research Site

20101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms

North Miami :

A clinical trial seeking patients for a research study for the treatment of Schizophrenia or Impaired Cognition

North Miami : Call for Information (Investigational Site 2022)

A clinical trial to evaluate treatments using Asenapine, Placebo Asenapine, Olanzapine and Placebo Olanzapine for patients with Schizophrenia

North Miami : Call for Information (Investigational Site 2013)

A clinical trial to evaluate treatments using Asenapine, Placebo Asenapine, Olanzapine and Placebo Olanzapine for patients with Schizophrenia

North Miami :

A Phase 3 clinical study for patients with Schizophrenia or Impaired Cognition

North Miami :

Patients are needed to participate in a clinical research study of EVP-6124 to evaluate Schizophrenia or Impaired Cognition

Oakland Park : Alkermes Investigational Site

A clinical trial to evaluate treatments for patients with Schizophrenia

Oakland Park : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Iloperidone and Placebo for the treatment of Schizophrenia

Oakland Park :

Patients are needed to participate in a clinical research study of EVP-6124 to evaluate Schizophrenia or Impaired Cognition

Orange City :

A clinical trial seeking patients for a research study for the treatment of Schizophrenia or Impaired Cognition

Orange City :

Patients are needed to participate in a clinical research study of EVP-6124 to evaluate Schizophrenia or Impaired Cognition

Orlando : Alkermes Investigational Site

A clinical trial to evaluate treatments for patients with Schizophrenia

Orlando :

A Phase 3 clinical study for patients with MDD

Orlando :

A Phase 3 clinical study for patients with Schizophrenia or Impaired Cognition

Sanford : Pfizer Investigational Site

A clinical trial to evaluate treatments using PF-02545920 and Placebo for patients with Schizophrenia

Sanford : Medical Research Group of Central Florida

Patients are needed to participate in a clinical research study of Lurasidone 20, 40, 60, 80 mg, flexibly dosed to evaluate Schizophrenia or Austism

Sanford : Medical Research Group of Central Florida

Patients are needed to participate in a clinical research study to evaluate Schizophrenia

Tampa :

A clinical trial to evaluate treatments using Brexpiprazole and Placebo for patients with Acute Schizophrenia

Georgia

Atlanta : NeuroTrials Research, Inc.

Tardive Dyskinesia in Schizophrenic Patients

Atlanta : Atlanta Center for Medical Research

The Atlanta Center for Medical Research is currently enrolling for a clinical trial evaluating an investigational drug for Schizophrenia

Atlanta : Atlanta Center for Medical Research

The Atlanta Center for Medical Research is currently enrolling for a clinical trial evaluating an investigational drug for Schizophrenia

Atlanta : Atlanta Center for Medical Research

The Atlanta Center for Medical Research is currently enrolling for a clinical trial evaluating an investigational drug for Schizophrenia

Atlanta : Research Site

20101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms

Atlanta : Research Site

20110165: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms

Atlanta :

A clinical research study of Brexpiprazole for the treatment of Major Depressive Disorder or Anxiety

Atlanta :

A clinical trial seeking patients for a research study for the treatment of Schizophrenia or Impaired Cognition

Atlanta : Alkermes Investigational Site

A clinical trial to evaluate treatments for patients with Schizophrenia

Atlanta : Novartis Investigative Site

A clinical trial to evaluate treatments using AQW051 and Placebo for patients with Schizophrenia

Atlanta :

A clinical trial to evaluate treatments using Aripiprazole and Ingestible Event Marker (IEM) for patients with Bipolar 1 Disorder, Schizophrenia, Mental Disorder or Nervous System Diseases

Atlanta :

A clinical trial to evaluate treatments using Brexpiprazole for patients with Schizophrenia

Atlanta : Pfizer Investigational Site

A clinical trial to evaluate treatments using PF-02545920 and Placebo for patients with Schizophrenia

Atlanta :

A Phase 3 clinical study for patients with MDD

Atlanta : Alkermes Investigational Site

Patients are needed to participate in a clinical research study evaluating ALKS 9072, Low and ALKS 9072, High for the treatment of Schizophrenia

Atlanta : Alkermes Investigational Site

Patients are needed to participate in a clinical research study evaluating ALKS 9072, Low dose, ALKS 9072, Med dose, ALKS 9072, High dose and Placebo for the treatment of Schizophrenia

Atlanta : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Iloperidone and Placebo for the treatment of Schizophrenia

Atlanta : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Iloperidone and Placebo for the treatment of Schizophrenia

Atlanta :

Patients are needed to participate in a clinical research study of EVP-6124 to evaluate Schizophrenia or Impaired Cognition

Atlanta : Atlanta Center for Medical Research

Patients are needed to participate in a clinical research study of Lurasidone 20, 40, 60, 80 mg, flexibly dosed to evaluate Schizophrenia or Austism

Atlanta :

Patients are needed to participate in a clinical research study to evaluate Psychotic Disorders, Schizophrenia, Bipolar Disorder or Depressive Disorder

Atlanta : Atlanta Center for Medical Research

Patients are needed to participate in a clinical research study to evaluate Schizophrenia

Decatur : Alkermes Investigational Site

A clinical trial to evaluate treatments for patients with Schizophrenia

Smyrna :

A Phase 3 clinical study for patients with Schizophrenia or Impaired Cognition

Smyrna : Attalla Consultants, LLC

Patients are needed to participate in a clinical research study of Lurasidone 20, 40, 60, 80 mg, flexibly dosed to evaluate Schizophrenia or Austism

Smyrna : Institute for Behavioral Medicine, LLC

Patients are needed to participate in a clinical research study to evaluate Schizophrenia

Illinois

Hoffman Estates : Alexian Brothers Hospital Network

A 17-week, Phase 2, Multicenter, Randomized, Double-Blind Study of Treatment with LY2140023 Combined with SOC to placebo Combined with SOC as the Treatment of Patients with DSM-IV-TR Schizophrenia with Prominent Negative Symptoms

Hoffman Estates : Alexian Brothers Hospital Network

A double-blind, placebo and active controlled evaluation of the safety and efficacy of Cariprazine in the acute exacerbation of Schizophrenia

Hoffman Estates : Alexian Brothers Hospital Network

A fifteen month, prospective, randomized, active-controlled, open-label, flexible dose study of paliperidone palmitate compared with oral antipsychotic treatment in delaying time to treatment failure in adults with schizophrenia who have been recently released from jail.

Hoffman Estates : Alexian Brothers Hospital Network

A phase 2, multicenter, double-blind placebo-controlled comparator study of 2 doses of LY2140023 versus placebo in patients with DSM-IV-TR Schizophrenia.

Hoffman Estates : Alexian Brothers Hospital Network

A Phase III, multi-center randomized, 24 week, double-blind, parallel group, placebo controlled study to evaluate efficacy and safety of RO4917838 in stable patients with persistent, predominant negative symptoms of schizophrenia treated with antipsychotics followed by a 28 week, double-blind treatment period

Hoffman Estates : Alexian Brothers Hospital Network

A phase III, multicenter, randomized, 12-week, double-blind, parallel group, placebo controlled study to evaluate the efficacy and safety of R04917838 in patients with sub-optimally controlled symptoms of schizophrenia treated with antipsychotics followed by a 40-week double-blind, parallel-group, placebo controlled treatment period.

Chicago : Research Site

20101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms

Chicago : Northwestern University

A clinical research study of Iloperidone for the treatment of Schizophrenia

Chicago :

A clinical trial seeking patients for a research study for the treatment of Schizophrenia or Impaired Cognition

Chicago : Alkermes Investigational Site

A clinical trial to evaluate treatments for patients with Schizophrenia

Chicago : Northwestern University Feinberg School of Medicine

A clinical trial to evaluate treatments using Eltoprazine and Placebo for patients with Cognitive Impairment or Schizophrenia

Chicago :

A Phase 3 clinical study for patients with Schizophrenia or Impaired Cognition

Chicago : Northwestern University Department of Psychiatry and Behavioral Sciences

A Phase 4 clinical study for patients with Schizophrenia

Chicago : Alkermes Investigational Site

Patients are needed to participate in a clinical research study evaluating ALKS 9072, Low and ALKS 9072, High for the treatment of Schizophrenia

Chicago : Alkermes Investigational Site

Patients are needed to participate in a clinical research study evaluating ALKS 9072, Low and ALKS 9072, High for the treatment of Schizophrenia

Chicago :

Patients are needed to participate in a clinical research study for the treatment of Schizophrenia

Chicago :

Patients are needed to participate in a clinical research study of EVP-6124 to evaluate Schizophrenia or Impaired Cognition

Chicago : University of Illinois at Chicago

Patients are needed to participate in a clinical research study of Risperdal Consta (drug) and Social Skills Training to evaluate Schizophrenia or Schizoaffective Disorder

Hoffman Estates :

A clinical trial to evaluate treatments using Brexpiprazole and Placebo for patients with Acute Schizophrenia

Hoffman Estates :

A clinical trial to evaluate treatments using Brexpiprazole for patients with Schizophrenia

Hoffman Estates : Pfizer Investigational Site

A clinical trial to evaluate treatments using PF-02545920 and Placebo for patients with Schizophrenia

Hoffman Estates : Alkermes Investigational Site

Patients are needed to participate in a clinical research study evaluating ALKS 9072, Low and ALKS 9072, High for the treatment of Schizophrenia

Hoffman Estates : Alkermes Investigational Site

Patients are needed to participate in a clinical research study evaluating ALKS 9072, Low dose, ALKS 9072, Med dose, ALKS 9072, High dose and Placebo for the treatment of Schizophrenia

Naperville : Baber Research Group

Patients are needed to participate in a clinical research study of Lurasidone 20, 40, 60, 80 mg, flexibly dosed to evaluate Schizophrenia or Austism

Oak Brook :

A Phase 3 clinical study for patients with Schizophrenia or Impaired Cognition

Oak Brook :

Patients are needed to participate in a clinical research study of EVP-6124 to evaluate Schizophrenia or Impaired Cognition

Oak Park :

A Phase 3 clinical study for patients with Schizophrenia or Impaired Cognition

Oak Park :

Patients are needed to participate in a clinical research study of EVP-6124 to evaluate Schizophrenia or Impaired Cognition

Schaumburg : Pfizer Investigational Site

A clinical trial to evaluate treatments using PF-02545920 and Placebo for patients with Schizophrenia

Indiana

Indianapolis : Prevention and Recovery Center for Early Psychosis

Patients are needed to participate in a clinical research study evaluating LY500307 25mg, LY500307 75mg and Placebo for the treatment of Schizophrenia

Indianapolis : Indiana University Center for NeuroImaging

Patients are needed to participate in a clinical research study evaluating LY500307 25mg, LY500307 75mg and Placebo for the treatment of Schizophrenia

Indianapolis : Larue D Carter Memorial Hospital

Patients are needed to participate in a clinical research study evaluating LY500307 25mg, LY500307 75mg and Placebo for the treatment of Schizophrenia

Lafayette :

A clinical research study of Brexpiprazole for the treatment of Major Depressive Disorder or Anxiety

Iowa

Iowa City :

Patients are needed to participate in a clinical research study for the treatment of Schizophrenia

Iowa City :

Patients are needed to participate in a clinical research study for the treatment of Schizophrenia

Iowa City :

Patients are needed to participate in a clinical research study for the treatment of Schizophrenia

Kansas

Wichita : Via Christi Research

Schizophrenia Treatment to Improve Thinking

Prairie Village :

A Phase 3 clinical study for patients with MDD

Topeka : Call for Information (Investigational Site 2020)

A clinical trial to evaluate treatments using Asenapine, Placebo Asenapine, Olanzapine and Placebo Olanzapine for patients with Schizophrenia

Wichita :

A clinical trial seeking patients for a research study for the treatment of Schizophrenia or Impaired Cognition

Wichita :

A Phase 3 clinical study for patients with Schizophrenia or Impaired Cognition

Wichita :

Patients are needed to participate in a clinical research study of EVP-6124 to evaluate Schizophrenia or Impaired Cognition

Louisiana

Lake Charles : Lake Charles Clinical Trials

Evaluating the efficacy and safety of RO4917838 in patients with poorly-controlled symptoms of schizophrenia

Lake Charles : Lake Charles Clinical Trials

Evaluating the efficacy and safety of RO4917838 in stable patients with persistent, predominant negative symptoms of schizophrenia

Lake Charles : Lake Charles Clinical Trials

Evaluating the efficacy of lurasidone for the maintenance treatment of adults with schizophrenia

Lake Charles : Lake Charles Clinical Trials

Study of ABT-126 in the Treatment of Cognitive Deficits in Schizophrenia (CDS) in Smokers

Lake Charles : Lake Charles Clinical Trials

Study of Aripiprazole (intramuscular injection) in the Acute Treatment of Adults with Schizophrenia

Lake Charles : Lake Charles Clinical Trials

Study of brexpiprazole in patients with acute schizophrenia

Lake Charles : Lake Charles Clinical Trials

Study of Low-Dose Lurasidone in Acutely Psychotic Subjects with Schizophrenia

Lake Charles : Lake Charles Clinical Trials

Study of OPC-34712 (brexpiprazole) as Treatment for Adults with Acute Schizophrenia

Lake Charles : Lake Charles Clinical Trials

Study of OPC-34712 as Long-Term Maintenance Treatment for Adults with Schizophrenia

Lake Charles : Alkermes Investigational Site

A clinical trial to evaluate treatments for patients with Schizophrenia

Lake Charles :

A clinical trial to evaluate treatments using Brexpiprazole for patients with Schizophrenia

Lake Charles : Pfizer Investigational Site

A clinical trial to evaluate treatments using PF-02545920 and Placebo for patients with Schizophrenia

Lake Charles :

A Phase 3 clinical study for patients with Schizophrenia or Impaired Cognition

Lake Charles :

Patients are needed to participate in a clinical research study of EVP-6124 to evaluate Schizophrenia or Impaired Cognition

Lake Charles : Lake Charles Clinical Trials LLC,2770 3rd Avenue,Suite 340

Patients are needed to participate in a clinical research study of Lurasidone 20, 40, 60, 80 mg, flexibly dosed to evaluate Schizophrenia or Austism

Lake Charles : Lake Charles Clinical Trials, LLC

Patients are needed to participate in a clinical research study to evaluate Schizophrenia

Shreveport :

A clinical trial seeking patients for a research study for the treatment of Schizophrenia or Impaired Cognition

Shreveport : Alkermes Investigational Site

A clinical trial to evaluate treatments for patients with Schizophrenia

Shreveport :

A Phase 3 clinical study for patients with Schizophrenia or Impaired Cognition

Shreveport :

Patients are needed to participate in a clinical research study of EVP-6124 to evaluate Schizophrenia or Impaired Cognition

Maryland

Baltimore :

A clinical research study of Brexpiprazole for the treatment of Major Depressive Disorder or Anxiety

Catonsville : Maryland Psychiatric Research Center

A clinical trial to evaluate treatments using Eltoprazine and Placebo for patients with Cognitive Impairment or Schizophrenia

Rockville : Research Site

20110165: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms

Rockville : Alkermes Investigational Site

A clinical trial to evaluate treatments for patients with Schizophrenia

Rockville : Pfizer Investigational Site

A clinical trial to evaluate treatments using PF-02545920 and Placebo for patients with Schizophrenia

Rockville :

A Phase 3 clinical study for patients with Schizophrenia or Impaired Cognition

Rockville : Alkermes Investigational Site

Patients are needed to participate in a clinical research study evaluating ALKS 9072, Low and ALKS 9072, High for the treatment of Schizophrenia

Massachusetts

Brockton : VA Boston Healthcare System New

Does schizophrenia run in your family?

Belmont :

Patients are needed to participate in a clinical research study for the treatment of Schizophrenia

Boston : Massachusetts General Hospital Updated

A clinical study for patients with Use of Atypical Antipsychotics During Pregnancy

Boston :

A clinical research study of Brexpiprazole for the treatment of Major Depressive Disorder or Anxiety

Boston : Massachusetts General Hospital

A clinical trial to evaluate treatments using Eltoprazine and Placebo for patients with Cognitive Impairment or Schizophrenia

Boston :

A Phase 3 clinical study for patients with Schizophrenia or Impaired Cognition

Boston : Massachusetts General Hospital

Intranasal Insulin Treatment in Patients With Schizophrenia

Boston :

Patients are needed to participate in a clinical research study of EVP-6124 to evaluate Schizophrenia or Impaired Cognition

Boston : Freedom Trail Clinic

Patients are needed to participate in a clinical research study to evaluate Schizophrenia or Schizoaffective Disorder

Haverhill :

A clinical research study of Brexpiprazole for the treatment of Major Depressive Disorder or Anxiety

Weymouth :

A Phase 3 clinical study for patients with MDD

Michigan

Bloomfield Hills : Neurobehavioral Medicine Group, PLLC

Patients are needed to participate in a clinical research study to evaluate Schizophrenia

Rochester Hills :

A clinical research study of Brexpiprazole for the treatment of Major Depressive Disorder or Anxiety

Minnesota

Minneapolis :

A clinical trial seeking patients for a research study for the treatment of Schizophrenia or Impaired Cognition

Minneapolis :

Patients are needed to participate in a clinical research study for the treatment of Schizophrenia

St. Paul :

Patients are needed to participate in a clinical research study for the treatment of Schizophrenia

St. Paul :

Patients are needed to participate in a clinical research study for the treatment of Schizophrenia

Mississippi

Flowood : Research Site

20110165: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms

Flowood :

A clinical trial seeking patients for a research study for the treatment of Schizophrenia or Impaired Cognition

Flowood : Alkermes Investigational Site

A clinical trial to evaluate treatments for patients with Schizophrenia

Flowood : Call for Information (Investigational Site 2012)

A clinical trial to evaluate treatments using Asenapine, Placebo Asenapine, Olanzapine and Placebo Olanzapine for patients with Schizophrenia

Flowood :

Patients are needed to participate in a clinical research study of EVP-6124 to evaluate Schizophrenia or Impaired Cognition

Missouri

Creve Coeur :

A clinical trial seeking patients for a research study for the treatment of Schizophrenia or Impaired Cognition

Creve Coeur : Alkermes Investigational Site

A clinical trial to evaluate treatments for patients with Schizophrenia

Creve Coeur :

Patients are needed to participate in a clinical research study of EVP-6124 to evaluate Schizophrenia or Impaired Cognition

O'Fallon :

A clinical trial seeking patients for a research study for the treatment of Schizophrenia or Impaired Cognition

O'Fallon : Pfizer Investigational Site

A clinical trial to evaluate treatments using PF-02545920 and Placebo for patients with Schizophrenia

O'Fallon :

Patients are needed to participate in a clinical research study of EVP-6124 to evaluate Schizophrenia or Impaired Cognition

St. Charles :

A clinical trial to evaluate treatments using Brexpiprazole and Placebo for patients with Acute Schizophrenia

St. Charles :

A Phase 3 clinical study for patients with Schizophrenia or Impaired Cognition

St. Charles :

Patients are needed to participate in a clinical research study of EVP-6124 to evaluate Schizophrenia or Impaired Cognition

St. Louis : Washington University

A clinical trial seeking patients for a research study for the treatment of Schizophrenia

St. Louis :

A clinical trial seeking patients for a research study for the treatment of Schizophrenia or Impaired Cognition

St. Louis : Alkermes Investigational Site

A clinical trial to evaluate treatments for patients with Schizophrenia

St. Louis :

A clinical trial to evaluate treatments using Brexpiprazole and Placebo for patients with Acute Schizophrenia

St. Louis : Pfizer Investigational Site

A clinical trial to evaluate treatments using PF-02545920 and Placebo for patients with Schizophrenia

St. Louis :

A clinical trial to evaluate treatments using Risperidone ISM for patients with Schizophrenia

St. Louis :

A Phase 3 clinical study for patients with Schizophrenia or Impaired Cognition

St. Louis : Alkermes Investigational Site

Patients are needed to participate in a clinical research study evaluating ALKS 9072, Low and ALKS 9072, High for the treatment of Schizophrenia

St. Louis : Alkermes Investigational Site

Patients are needed to participate in a clinical research study evaluating ALKS 9072, Low dose, ALKS 9072, Med dose, ALKS 9072, High dose and Placebo for the treatment of Schizophrenia

St. Louis : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Iloperidone and Placebo for the treatment of Schizophrenia

St. Louis :

Patients are needed to participate in a clinical research study of EVP-6124 to evaluate Schizophrenia or Impaired Cognition

St. Louis : Novartis Investigative Site

Patients are needed to participate in a clinical research study of iloperidone (oral tablet) to evaluate Safety and Tolerability of Iloperidone

Nebraska

Lincoln :

A Phase 3 clinical study for patients with Schizophrenia or Impaired Cognition

Lincoln :

Patients are needed to participate in a clinical research study of EVP-6124 to evaluate Schizophrenia or Impaired Cognition

Omaha :

A clinical trial seeking patients for a research study for the treatment of Schizophrenia or Impaired Cognition

Omaha :

Patients are needed to participate in a clinical research study of EVP-6124 to evaluate Schizophrenia or Impaired Cognition

Nevada

Las Vegas :

A clinical trial to evaluate treatments using Brexpiprazole and Placebo for patients with Acute Schizophrenia

Las Vegas :

A Phase 3 clinical study for patients with MDD

New Hampshire

Nashua : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Iloperidone and Placebo for the treatment of Schizophrenia

New Jersey

Mount Laurel : CRI Lifetree

Do you or a loved one suffer from Schizophrenia or Schizoaffective Disorder?

Marlton : Research Site

20101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms

Marlton :

A clinical trial seeking patients for a research study for the treatment of Schizophrenia or Impaired Cognition

Marlton : Alkermes Investigational Site

A clinical trial to evaluate treatments for patients with Schizophrenia

Marlton : Novartis Investigative Site

A clinical trial to evaluate treatments using AQW051 and Placebo for patients with Schizophrenia

Princeton :

A Phase 3 clinical study for patients with Schizophrenia or Impaired Cognition

Princeton :

Patients are needed to participate in a clinical research study of EVP-6124 to evaluate Schizophrenia or Impaired Cognition

Toms River : Childrens Specialized Hospital

Patients are needed to participate in a clinical research study of Lurasidone 20, 40, 60, 80 mg, flexibly dosed to evaluate Schizophrenia or Austism

Willingboro : Call for Information (Investigational Site 2008)

A clinical trial to evaluate treatments using Asenapine, Placebo Asenapine, Olanzapine and Placebo Olanzapine for patients with Schizophrenia

Willingboro : Alkermes Investigational Site

Patients are needed to participate in a clinical research study evaluating ALKS 9072, Low dose, ALKS 9072, Med dose, ALKS 9072, High dose and Placebo for the treatment of Schizophrenia

Willingboro : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Iloperidone and Placebo for the treatment of Schizophrenia

New Mexico

Albuquerque : New Mexico VA Healthcare System

A clinical study for patients with Schizophrenia or Sensory Gating

Albuquerque :

A clinical trial seeking patients for a research study for the treatment of Schizophrenia or Impaired Cognition

Albuquerque :

Patients are needed to participate in a clinical research study of EVP-6124 to evaluate Schizophrenia or Impaired Cognition

New York

Brooklyn :

A Phase 3 clinical study for patients with MDD

Brooklyn : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Iloperidone and Placebo for the treatment of Schizophrenia

Cedarhurst :

A clinical trial seeking patients for a research study for the treatment of Schizophrenia or Impaired Cognition

Cedarhurst :

Patients are needed to participate in a clinical research study of EVP-6124 to evaluate Schizophrenia or Impaired Cognition

Glen Oaks : Research Site

20101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms

Jamaica : Pfizer Investigational Site

A clinical trial to evaluate treatments using PF-02545920 and Placebo for patients with Schizophrenia

Jamaica :

A Phase 3 clinical study for patients with MDD

New York : Research Site

20110165: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms

New York :

A clinical research study of Brexpiprazole for the treatment of Major Depressive Disorder or Anxiety

New York :

A clinical trial seeking patients for a research study for the treatment of Schizophrenia

New York :

A clinical trial seeking patients for a research study for the treatment of Schizophrenia or Impaired Cognition

New York : Research Foundation for Mental Hygiene, Inc.

A clinical trial to evaluate treatments using Eltoprazine and Placebo for patients with Cognitive Impairment or Schizophrenia

New York :

A Phase 3 clinical study for patients with Schizophrenia or Impaired Cognition

New York : Columbia University

Patients are needed to participate in a clinical research study evaluating Brexpiprazole 1mg to 4mg for the treatment of Schizophrenia

New York :

Patients are needed to participate in a clinical research study for the treatment of Schizophrenia

New York :

Patients are needed to participate in a clinical research study for the treatment of Schizophrenia

New York :

Patients are needed to participate in a clinical research study for the treatment of Schizophrenia

New York :

Patients are needed to participate in a clinical research study for the treatment of Schizophrenia

New York :

Patients are needed to participate in a clinical research study for the treatment of Schizophrenia

New York :

Patients are needed to participate in a clinical research study for the treatment of Schizophrenia

New York :

Patients are needed to participate in a clinical research study of EVP-6124 to evaluate Schizophrenia or Impaired Cognition

Orangeburg :

Patients are needed to participate in a clinical research study for the treatment of Schizophrenia

Rochester : Research Site

20101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms

Rochester :

A clinical trial to evaluate treatments using Brexpiprazole for patients with Schizophrenia

Rochester :

A Phase 3 clinical study for patients with Schizophrenia or Impaired Cognition

Rochester : Finger Lakes Clinical Research

Patients are needed to participate in a clinical research study of Lurasidone 20, 40, 60, 80 mg, flexibly dosed to evaluate Schizophrenia or Austism

Rochester : Finger Lakes Clinical Research

Patients are needed to participate in a clinical research study to evaluate Schizophrenia

Staten Island :

A clinical research study of Brexpiprazole for the treatment of Major Depressive Disorder or Anxiety

Staten Island :

A Phase 3 clinical study for patients with MDD

Staten Island : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Iloperidone and Placebo for the treatment of Schizophrenia

Staten Island : Richmond Behavioral Associates

Patients are needed to participate in a clinical research study of Lurasidone 20, 40, 60, 80 mg, flexibly dosed to evaluate Schizophrenia or Austism

Staten Island : Richmond Behavioral Associates

Patients are needed to participate in a clinical research study to evaluate Schizophrenia

North Carolina

Carrboro :

Patients are needed to participate in a clinical research study for the treatment of Schizophrenia

Cary :

Patients are needed to participate in a clinical research study for the treatment of Schizophrenia

Chapel Hill :

Patients are needed to participate in a clinical research study for the treatment of Schizophrenia

Charlotte :

A clinical trial seeking patients for a research study for the treatment of Schizophrenia or Impaired Cognition

Charlotte :

A Phase 3 clinical study for patients with Schizophrenia or Impaired Cognition

Charlotte :

Patients are needed to participate in a clinical research study of EVP-6124 to evaluate Schizophrenia or Impaired Cognition

Durham : Research Site

20110165: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms

Durham :

A clinical trial seeking patients for a research study for the treatment of Schizophrenia or Impaired Cognition

Durham : Duke University School of Medicine

A clinical trial to evaluate treatments using Eltoprazine and Placebo for patients with Cognitive Impairment or Schizophrenia

Durham :

Patients are needed to participate in a clinical research study for the treatment of Schizophrenia

Durham :

Patients are needed to participate in a clinical research study for the treatment of Schizophrenia

Durham :

Patients are needed to participate in a clinical research study for the treatment of Schizophrenia

Hickory : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Iloperidone and Placebo for the treatment of Schizophrenia

Hillsborough :

Patients are needed to participate in a clinical research study for the treatment of Schizophrenia

Pinehurst :

Patients are needed to participate in a clinical research study for the treatment of Schizophrenia

Raleigh : Research Site

20101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms

Ohio

Beachwood :

A Phase 3 clinical study for patients with Schizophrenia or Impaired Cognition

Beachwood : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Iloperidone and Placebo for the treatment of Schizophrenia

Canton : Alkermes Investigational Site

A clinical trial to evaluate treatments for patients with Schizophrenia

Cincinnati :

Patients are needed to participate in a clinical research study for the treatment of Schizophrenia

Cincinnati : Novartis Investigative Site

Patients are needed to participate in a clinical research study of iloperidone (oral tablet) to evaluate Safety and Tolerability of Iloperidone

Cincinnati : University of Cincinnati Medical Center

Patients are needed to participate in a clinical research study of Lurasidone 20, 40, 60, 80 mg, flexibly dosed to evaluate Schizophrenia or Austism

Cincinnati : University of Cincinnati Medical Center

Patients are needed to participate in a clinical research study to evaluate Schizophrenia

Cleveland :

A clinical trial seeking patients for a research study for the treatment of Schizophrenia or Impaired Cognition

Cleveland :

Patients are needed to participate in a clinical research study of EVP-6124 to evaluate Schizophrenia or Impaired Cognition

Dayton : Research Site

20101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms

Dayton :

A clinical trial to evaluate treatments using Aripiprazole and Ingestible Event Marker (IEM) for patients with Bipolar 1 Disorder, Schizophrenia, Mental Disorder or Nervous System Diseases

Dayton : Pfizer Investigational Site

A clinical trial to evaluate treatments using PF-02545920 and Placebo for patients with Schizophrenia

Mason : Alkermes Investigational Site

A clinical trial to evaluate treatments for patients with Schizophrenia

Shaker Heights :

Patients are needed to participate in a clinical research study of EVP-6124 to evaluate Schizophrenia or Impaired Cognition

Oklahoma

Oklahoma City :

A clinical trial seeking patients for a research study for the treatment of Schizophrenia or Impaired Cognition

Oklahoma City : Alkermes Investigational Site

A clinical trial to evaluate treatments for patients with Schizophrenia

Oklahoma City : Pfizer Investigational Site

A clinical trial to evaluate treatments using PF-02545920 and Placebo for patients with Schizophrenia

Oklahoma City :

A Phase 3 clinical study for patients with Schizophrenia or Impaired Cognition

Oklahoma City :

Patients are needed to participate in a clinical research study of EVP-6124 to evaluate Schizophrenia or Impaired Cognition

Oklahoma City : Cutting Edge Research Group

Patients are needed to participate in a clinical research study of Lurasidone 20, 40, 60, 80 mg, flexibly dosed to evaluate Schizophrenia or Austism

Oregon

Gresham : Cyn3rgy Research & Development

Patients are needed to participate in a clinical research study of Lurasidone 20, 40, 60, 80 mg, flexibly dosed to evaluate Schizophrenia or Austism

Portland :

A Phase 3 clinical study for patients with MDD

Salem :

A clinical research study of Brexpiprazole for the treatment of Major Depressive Disorder or Anxiety

Pennsylvania

Allentown :

A clinical research study of Brexpiprazole for the treatment of Major Depressive Disorder or Anxiety

Conshohocken :

A clinical trial seeking patients for a research study for the treatment of Schizophrenia or Impaired Cognition

Conshohocken :

Patients are needed to participate in a clinical research study of EVP-6124 to evaluate Schizophrenia or Impaired Cognition

Jenkintown :

A Phase 3 clinical study for patients with Schizophrenia or Impaired Cognition

Jenkintown :

Patients are needed to participate in a clinical research study of EVP-6124 to evaluate Schizophrenia or Impaired Cognition

Norristown :

A clinical trial seeking patients for a research study for the treatment of Schizophrenia or Impaired Cognition

Norristown :

Patients are needed to participate in a clinical research study of EVP-6124 to evaluate Schizophrenia or Impaired Cognition

Philadelphia :

A clinical trial seeking patients for a research study for the treatment of Schizophrenia or Impaired Cognition

Philadelphia : Alkermes Investigational Site

A clinical trial to evaluate treatments for patients with Schizophrenia

Philadelphia : Novartis Investigative Site

A clinical trial to evaluate treatments using AQW051 and Placebo for patients with Schizophrenia

Philadelphia : Call for Information (Investigational Site 2018)

A clinical trial to evaluate treatments using Asenapine, Placebo Asenapine, Olanzapine and Placebo Olanzapine for patients with Schizophrenia

Philadelphia :

A clinical trial to evaluate treatments using Brexpiprazole for patients with Schizophrenia

Philadelphia : Alkermes Investigational Site

Patients are needed to participate in a clinical research study evaluating ALKS 9072, Low and ALKS 9072, High for the treatment of Schizophrenia

Philadelphia : Alkermes Investigational Site

Patients are needed to participate in a clinical research study evaluating ALKS 9072, Low dose, ALKS 9072, Med dose, ALKS 9072, High dose and Placebo for the treatment of Schizophrenia

Philadelphia : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Iloperidone and Placebo for the treatment of Schizophrenia

Philadelphia :

Patients are needed to participate in a clinical research study of EVP-6124 to evaluate Schizophrenia or Impaired Cognition

Pittsburgh : University of Pittsburgh

A clinical study for patients with Schizophrenia, Schizoaffective Disorder or Delusional Disorder

Scranton : Research Site

20110165: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms

South Carolina

Charleston : Medical University of South Carolina

A clinical research study of Green Tea and Placebo for the treatment of Bipolar Disorder or Schizophrenia

Charleston : Alkermes Investigational Site

A clinical trial to evaluate treatments for patients with Schizophrenia

Charleston : Call for Information (Investigational Site 2002)

A clinical trial to evaluate treatments using Asenapine, Placebo Asenapine, Olanzapine and Placebo Olanzapine for patients with Schizophrenia

Charleston : Alkermes Investigational Site

Patients are needed to participate in a clinical research study evaluating ALKS 9072, Low and ALKS 9072, High for the treatment of Schizophrenia

Tennessee

Memphis : Research Site

20110165: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms

Memphis : Alkermes Investigational Site

A clinical trial to evaluate treatments for patients with Schizophrenia

Memphis :

A clinical trial to evaluate treatments using Brexpiprazole and Placebo for patients with Acute Schizophrenia

Memphis :

A clinical trial to evaluate treatments using Brexpiprazole for patients with Schizophrenia

Memphis : Pfizer Investigational Site

A clinical trial to evaluate treatments using PF-02545920 and Placebo for patients with Schizophrenia

Memphis : Research Strategies of Memphis, LLC

Patients are needed to participate in a clinical research study to evaluate Schizophrenia

Nashville : Vanderbilt Psychiatric Hospital

Patients are needed to participate in a clinical research study of long-acting injectable risperidone and long acting injectable risperidone to evaluate Schizophrenia or Schizoaffective Disorder

Texas

Arlington :

A clinical research study of Brexpiprazole for the treatment of Major Depressive Disorder or Anxiety

Austin :

A clinical research study of Brexpiprazole for the treatment of Major Depressive Disorder or Anxiety

Austin : Alkermes Investigational Site

A clinical trial to evaluate treatments for patients with Schizophrenia

Austin : Alkermes Investigational Site

A clinical trial to evaluate treatments for patients with Schizophrenia

Austin : Call for Information (Investigational Site 2001)

A clinical trial to evaluate treatments using Asenapine, Placebo Asenapine, Olanzapine and Placebo Olanzapine for patients with Schizophrenia

Austin : Call for Information (Investigational Site 2007)

A clinical trial to evaluate treatments using Asenapine, Placebo Asenapine, Olanzapine and Placebo Olanzapine for patients with Schizophrenia

Austin : Pfizer Investigational Site

A clinical trial to evaluate treatments using PF-02545920 and Placebo for patients with Schizophrenia

Austin : Pfizer Investigational Site

A clinical trial to evaluate treatments using PF-02545920 and Placebo for patients with Schizophrenia

Austin :

A Phase 3 clinical study for patients with Schizophrenia or Impaired Cognition

Austin : Alkermes Investigational Site

Patients are needed to participate in a clinical research study evaluating ALKS 9072, Low and ALKS 9072, High for the treatment of Schizophrenia

Austin : Alkermes Investigational Site

Patients are needed to participate in a clinical research study evaluating ALKS 9072, Low and ALKS 9072, High for the treatment of Schizophrenia

Austin :

Patients are needed to participate in a clinical research study of EVP-6124 to evaluate Schizophrenia or Impaired Cognition

Austin : Community Clinical Research Inc

Patients are needed to participate in a clinical research study of LY03004 to evaluate Schizophrenia or Schizoaffective Disorder

Austin :

Patients are needed to participate in a clinical research study to evaluate Psychotic Disorders, Schizophrenia, Bipolar Disorder or Depressive Disorder

Austin : BioBehavioral Research of Austin

Patients are needed to participate in a clinical research study to evaluate Schizophrenia

Dallas : Research Site

20110165: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms

Dallas :

A clinical trial seeking patients for a research study for the treatment of Schizophrenia or Impaired Cognition

Dallas : Alkermes Investigational Site

A clinical trial to evaluate treatments for patients with Schizophrenia

Dallas : Alkermes Investigational Site

A clinical trial to evaluate treatments for patients with Schizophrenia

Dallas : Call for Information (Investigational Site 2005)

A clinical trial to evaluate treatments using Asenapine, Placebo Asenapine, Olanzapine and Placebo Olanzapine for patients with Schizophrenia

Dallas :

A clinical trial to evaluate treatments using Brexpiprazole and Placebo for patients with Acute Schizophrenia

Dallas :

A clinical trial to evaluate treatments using Brexpiprazole for patients with Schizophrenia

Dallas :

A clinical trial to evaluate treatments using Brexpiprazole for patients with Schizophrenia

Dallas : Pfizer Investigational Site

A clinical trial to evaluate treatments using PF-02545920 and Placebo for patients with Schizophrenia

Dallas : Pfizer Investigational Site

A clinical trial to evaluate treatments using PF-02545920 and Placebo for patients with Schizophrenia

Dallas :

A Phase 3 clinical study for patients with Schizophrenia or Impaired Cognition

Dallas : Alkermes Investigational Site

Patients are needed to participate in a clinical research study evaluating ALKS 9072, Low and ALKS 9072, High for the treatment of Schizophrenia

Dallas : Alkermes Investigational Site

Patients are needed to participate in a clinical research study evaluating ALKS 9072, Low and ALKS 9072, High for the treatment of Schizophrenia

Dallas :

Patients are needed to participate in a clinical research study of EVP-6124 to evaluate Schizophrenia or Impaired Cognition

Dallas : Pillar Clinical Research, LLC

Patients are needed to participate in a clinical research study to evaluate Schizophrenia

Desoto : Alkermes Investigational Site

A clinical trial to evaluate treatments for patients with Schizophrenia

DeSoto : Pfizer Investigational Site

A clinical trial to evaluate treatments using PF-02545920 and Placebo for patients with Schizophrenia

Houston : Research Site

20101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms

Houston : Alkermes Investigational Site

A clinical trial to evaluate treatments for patients with Schizophrenia

Houston : Alkermes Investigational Site

A clinical trial to evaluate treatments for patients with Schizophrenia

Houston :

A clinical trial to evaluate treatments using Brexpiprazole for patients with Schizophrenia

Houston :

A Phase 3 clinical study for patients with MDD

Irving : Novartis Investigative Site

A clinical trial to evaluate treatments using AQW051 and Placebo for patients with Schizophrenia

Irving :

A clinical trial to evaluate treatments using Aripiprazole and Ingestible Event Marker (IEM) for patients with Bipolar 1 Disorder, Schizophrenia, Mental Disorder or Nervous System Diseases

Irving : Alkermes Investigational Site

Patients are needed to participate in a clinical research study evaluating ALKS 9072, Low dose, ALKS 9072, Med dose, ALKS 9072, High dose and Placebo for the treatment of Schizophrenia

Irving : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Iloperidone and Placebo for the treatment of Schizophrenia

Lytle :

Patients are needed to participate in a clinical research study for the treatment of Schizophrenia

Round Rock :

Patients are needed to participate in a clinical research study for the treatment of Schizophrenia

San Antonio :

A Phase 3 clinical study for patients with MDD

San Antonio :

Patients are needed to participate in a clinical research study for the treatment of Schizophrenia

San Antonio :

Patients are needed to participate in a clinical research study for the treatment of Schizophrenia

Taylor :

Patients are needed to participate in a clinical research study for the treatment of Schizophrenia

The Woodlands : Family Psychiatry of The Woodlands, P.A.

Patients are needed to participate in a clinical research study of Lurasidone 20, 40, 60, 80 mg, flexibly dosed to evaluate Schizophrenia or Austism

The Woodlands : Family Psychiatry of The Woodlands, P.A.

Patients are needed to participate in a clinical research study to evaluate Schizophrenia

Utah

Salt lake City : Lifetree Clinical Research

A multicenter, randomized, double-blind, placebo-controlled, parallel-group study to evaluate prevention of relapse in patients with schizophrenia receiving either flexible dose iloperidone or placebo in long-term use (up to 26 weeks) followed by up to 52 weeks of open-label extension

Salt Lake City : CRI Lifetree

A multicenter, randomized, double-blind, placebocontrolled, parallel-group study to evaluate prevention of relapse in patients with schizophrenia receiving either flexible dose iloperidone or placebo in long-term use (up to 26 weeks) followed by up to 52 weeks of open-label extension

Salt Lake City : CRI Lifetree

A Randomized, Multicenter, Double-Blind, Relapse Prevention Study of Paliperidone Palmitate 3-Month Formulation for the Treatment of Subjects with Schizophrenia

Salt lake City : Lifetree Clinical Research

Mosaic: The Management of Schizophrenia in Clinical Practice

Salt Lake City : CRI Lifetree

The primary objective of this study is to evaluate the efficacy of PP3M compared with placebo in delay of the time to first occurrence of relapse of the symptoms of schizophrenia.

Salt lake City : Lifetree Clinical Research

The primary objective of this study is to evaluate the efficacy of PP3M compared with placebo in delay of the time to first occurrence of relapse of the symptoms of schizophrenia.

Clinton : Ericksen Research & Development, LLC

Patients are needed to participate in a clinical research study of Lurasidone 20, 40, 60, 80 mg, flexibly dosed to evaluate Schizophrenia or Austism

Orem : Aspen Clinical Research

Patients are needed to participate in a clinical research study to evaluate Schizophrenia

Salt Lake City : Alkermes Investigational Site

A clinical trial to evaluate treatments for patients with Schizophrenia

Salt Lake City : Pfizer Investigational Site

A clinical trial to evaluate treatments using PF-02545920 and Placebo for patients with Schizophrenia

Salt Lake City : Pfizer Investigational Site

A clinical trial to evaluate treatments using PF-02545920 and Placebo for patients with Schizophrenia

Salt Lake City :

A Phase 3 clinical study for patients with Schizophrenia or Impaired Cognition

Salt Lake City : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Iloperidone and Placebo for the treatment of Schizophrenia

Salt Lake City :

Patients are needed to participate in a clinical research study for the treatment of Schizophrenia

Salt Lake City :

Patients are needed to participate in a clinical research study of EVP-6124 to evaluate Schizophrenia or Impaired Cognition

Salt Lake City : CRI Lifetree

Patients are needed to participate in a clinical research study of Lurasidone 20, 40, 60, 80 mg, flexibly dosed to evaluate Schizophrenia or Austism

Vermont

Woodstock :

A clinical research study of Brexpiprazole for the treatment of Major Depressive Disorder or Anxiety

Virginia

Herndon : Neuroscience, Inc.

Patients are needed to participate in a clinical research study of Lurasidone 20, 40, 60, 80 mg, flexibly dosed to evaluate Schizophrenia or Austism

Richmond :

A clinical research study of Brexpiprazole for the treatment of Major Depressive Disorder or Anxiety

Richmond :

A clinical trial to evaluate treatments using Brexpiprazole and Placebo for patients with Acute Schizophrenia

Washington

Bellevue : Alkermes Investigational Site

A clinical trial to evaluate treatments for patients with Schizophrenia

Bothell : Pacific Institute Of Medical Sciences

Patients are needed to participate in a clinical research study of Lurasidone 20, 40, 60, 80 mg, flexibly dosed to evaluate Schizophrenia or Austism

Bothell : Pacific Institute Of Medical Sciences

Patients are needed to participate in a clinical research study to evaluate Schizophrenia

Richland :

A Phase 3 clinical study for patients with Schizophrenia or Impaired Cognition

Seattle :

A Phase 3 clinical study for patients with MDD

Spokane :

A Phase 3 clinical study for patients with Schizophrenia or Impaired Cognition

Spokane :

Patients are needed to participate in a clinical research study of EVP-6124 to evaluate Schizophrenia or Impaired Cognition

Tacoma :

Patients are needed to participate in a clinical research study for the treatment of Schizophrenia

Australia

Epping : Updated

A clinical research study for the treatment of Schizophrenia

Everton Park : Updated

A clinical research study for the treatment of Schizophrenia

Glenside : Research Site

20101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms

Meadowbrook, QLD :

A Phase 3 clinical study for patients with Schizophrenia or Impaired Cognition

Melbourne : Research Site

20101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms

Melbourne :

A clinical trial seeking patients for a research study for the treatment of Schizophrenia or Impaired Cognition

Mt Claremont : Research Site

20101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms

Belgium

Diest :

A clinical trial seeking patients for a research study for the treatment of Schizophrenia

Duffel : Psychiatrisch Ziekenhuis St Norbertus

A clinical research study of [18F]-PBR111 PET, Cognitive and psychomotor tasks and Blood sampling for the treatment of Schizophrenia or Psychosis

Duffel :

A clinical trial to evaluate treatments using Cognitive Test Battery 1 and Cognitive Test Battery 2 for patients with Schizophrenia

Kortenberg : University Psychiatric Institute Sint-Jozef

A clinical trial to evaluate treatments using Pipamperone and sugar pill for patients with Chronic Schizophrenia or Schizoaffective Disorder

Bulgaria

Burgas : Alkermes Investigational Site

A clinical trial to evaluate treatments for patients with Schizophrenia

Kazanlak : Alkermes Investigational Site

A clinical trial to evaluate treatments for patients with Schizophrenia

Lovech : Alkermes Investigational Site

A clinical trial to evaluate treatments for patients with Schizophrenia

Novi Iskar : Alkermes Investigational Site

Patients are needed to participate in a clinical research study evaluating ALKS 9072, Low and ALKS 9072, High for the treatment of Schizophrenia

Pazardzhik : Alkermes Investigational Site

A clinical trial to evaluate treatments for patients with Schizophrenia

Pazardzhik : Alkermes Investigational Site

Patients are needed to participate in a clinical research study evaluating ALKS 9072, Low and ALKS 9072, High for the treatment of Schizophrenia

Sofia : Merck Sharp & Dohme Bulgaria EOOD

A clinical trial to evaluate treatments using Asenapine, Placebo Asenapine, Olanzapine and Placebo Olanzapine for patients with Schizophrenia

Tserova Koria : Alkermes Investigational Site

A clinical trial to evaluate treatments for patients with Schizophrenia

Varna : Alkermes Investigational Site

A clinical trial to evaluate treatments for patients with Schizophrenia

Vratsa : Alkermes Investigational Site

A clinical trial to evaluate treatments for patients with Schizophrenia

Canada

Calgary : Research Site

20101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms

Calgary :

A clinical trial seeking patients for a research study for the treatment of Schizophrenia or Impaired Cognition

Chatham :

A clinical trial seeking patients for a research study for the treatment of Schizophrenia or Impaired Cognition

Kingston : Research Site

20101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms

Kingston :

A clinical trial seeking patients for a research study for the treatment of Schizophrenia or Impaired Cognition

Montreal : Research Site

20101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms

Penticton : Research Site

20101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms

Penticton :

A clinical trial seeking patients for a research study for the treatment of Schizophrenia or Impaired Cognition

Penticton :

Patients are needed to participate in a clinical research study of EVP-6124 to evaluate Schizophrenia or Impaired Cognition

Toronto : Centre for Addiction and Mental Health

A clinical research study of Varenicline and Placebo for the treatment of Craving, Smoking or Schizophrenia.

Toronto : Centre for Addiction and Mental Health

A clinical trial seeking patients for a research study for the treatment of Tardive Dyskinesia

Toronto : Centre for Addiction and Mental Health (33 Russell street)

A clinical trial to evaluate treatments using Varenicline for patients with Schizophrenia or Schizoaffective Disorder

Toronto : Centre for Addiction and Mental Health

Patients are needed to participate in a clinical research study evaluating Varenicline and Placebo for the treatment of Schizophrenia

Victoria : Vancouver Island Health Authority

A clinical trial seeking patients for a research study for the treatment of Tardive Dyskinesia

Windsor : Windsor Regional Hospital

A clinical trial seeking patients for a research study for the treatment of Tardive Dyskinesia

China

Beijing : Institute of mental health, Peking University

A clinical trial to evaluate treatments for patients with Prescription

Changsha : Mental Health Institute

A Phase 4 clinical study for patients with Schizophrenia

Changsha :

Patients are needed to participate in a clinical research study evaluating Paliperidone Palmitate for the treatment of Schizophrenia

Guangzhou :

Patients are needed to participate in a clinical research study evaluating Paliperidone Palmitate for the treatment of Schizophrenia

Hong Kong : Kwai Chung Hospital

Patients are needed to participate in a clinical research study evaluating Long-acting Risperidone microspheres injection

Nanjing :

Patients are needed to participate in a clinical research study evaluating Paliperidone Palmitate for the treatment of Schizophrenia

Wuhan :

Patients are needed to participate in a clinical research study evaluating Paliperidone Palmitate for the treatment of Schizophrenia

Colombia

Barranquilla :

A clinical trial to evaluate treatments using Brexpiprazole and Placebo for patients with Acute Schizophrenia

Barranquilla :

A Phase 3 clinical study for patients with Schizophrenia or Impaired Cognition

Bello : E.S.E. Hospital Mental de Antioquia

A clinical trial seeking patients for a research study for the treatment of Schizophrenia

Bello :

A clinical trial to evaluate treatments using Brexpiprazole and Placebo for patients with Acute Schizophrenia

Bogota : Instituto Colombiano del Sistema Nervioso - Clinica Montserrat

A clinical trial seeking patients for a research study for the treatment of Schizophrenia

Bogota : Centro de Investigaciones del Sistema Nervioso Limitada - Grupo CISNE Ltda

A clinical trial seeking patients for a research study for the treatment of Schizophrenia

Bogota :

A clinical trial to evaluate treatments using Brexpiprazole and Placebo for patients with Acute Schizophrenia

Bogota D.C. :

A Phase 3 clinical study for patients with Schizophrenia or Impaired Cognition

Pereira :

A clinical trial to evaluate treatments using Brexpiprazole and Placebo for patients with Acute Schizophrenia

Pereira :

A Phase 3 clinical study for patients with Schizophrenia or Impaired Cognition

Croatia

Zagreb : Merck Sharp & Dohme d.o.o

A clinical trial to evaluate treatments using Asenapine, Placebo Asenapine, Olanzapine and Placebo Olanzapine for patients with Schizophrenia

Czech Republic

Brno : Research Site

20110165: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms

Brno-mesto : Alkermes Investigational Site

A clinical trial to evaluate treatments for patients with Schizophrenia

Olomouc : Research Site

20110165: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms

Olomouc : Updated

A clinical research study for the treatment of Schizophrenia

Plzen : Updated

A clinical research study for the treatment of Schizophrenia

Praha 10 : Updated

A clinical research study for the treatment of Schizophrenia

Praha 2 : Research Site

20110165: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms

Praha 2 : Updated

A clinical research study for the treatment of Schizophrenia

Praha 8 - Bohnice : Updated

A clinical research study for the treatment of Schizophrenia

Praha 9 : Research Site

20110165: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms

Prerov : Research Site

20110165: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms

Strakonice : Research Site

20110165: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms

Denmark

Aalborg : Aalborg University Hospital, Aalborg Psychiatric Hospital, Centre for Schizophrenia

A clinical trial to evaluate treatments using Pregabalin and Pregabalin Placebo Capsules for patients with Schizophrenia or Anxiety-comorbidity to Schizophrenia

Helsingør :

A clinical trial seeking patients for a research study for the treatment of Schizophrenia

Kobenhavn S :

A clinical trial seeking patients for a research study for the treatment of Schizophrenia

France

Bohars : Updated

A clinical research study for the treatment of Schizophrenia

Bron : Updated

A clinical research study for the treatment of Schizophrenia

Brumath : Updated

A clinical research study for the treatment of Schizophrenia

Clermont Ferrand : Research Site

20110165: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms

Créteil cedex : Research Site

20110165: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms

Dôle : Research Site

20110165: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms

Digne Les Bains : Updated

A clinical research study for the treatment of Schizophrenia

Leyme : Updated

A clinical research study for the treatment of Schizophrenia

Montauban cedex : Research Site

20110165: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms

Montpellier : Updated

A clinical research study for the treatment of Schizophrenia

Nice : Updated

A clinical research study for the treatment of Schizophrenia

Nimes : Research Site

20110165: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms

Novillars : Updated

A clinical research study for the treatment of Schizophrenia

Paris : Updated

A clinical research study for the treatment of Schizophrenia

Poitiers : Updated

A clinical research study for the treatment of Schizophrenia

Pontarlier : Updated

A clinical research study for the treatment of Schizophrenia

Provins : Updated

A clinical research study for the treatment of Schizophrenia

Reims : Updated

A clinical research study for the treatment of Schizophrenia

Rennes : Updated

A clinical research study for the treatment of Schizophrenia

Saint Egreve : Updated

A clinical research study for the treatment of Schizophrenia

Saint Nazaire : Updated

A clinical research study for the treatment of Schizophrenia

Sens : Updated

A clinical research study for the treatment of Schizophrenia

Verdun : Updated

A clinical research study for the treatment of Schizophrenia

Germany

Achim :

A clinical trial seeking patients for a research study for the treatment of Schizophrenia or Impaired Cognition

Berlin :

A clinical trial seeking patients for a research study for the treatment of Schizophrenia

Berlin :

A clinical trial seeking patients for a research study for the treatment of Schizophrenia or Impaired Cognition

Chemnitz :

A clinical trial seeking patients for a research study for the treatment of Schizophrenia

Dresden :

A clinical trial seeking patients for a research study for the treatment of Schizophrenia

Dusseldorf :

A clinical trial seeking patients for a research study for the treatment of Schizophrenia or Impaired Cognition

Greifswald :

A clinical trial seeking patients for a research study for the treatment of Schizophrenia

Leipzig :

A clinical trial seeking patients for a research study for the treatment of Schizophrenia or Impaired Cognition

Mannheim : Central Institute of Mental Health

A clinical trial seeking patients for a research study for the treatment of Schizophrenia or Schizophrenia-spectrum-disorders

Mittweida :

A clinical trial seeking patients for a research study for the treatment of Schizophrenia or Impaired Cognition

Munchen :

A clinical trial seeking patients for a research study for the treatment of Schizophrenia or Impaired Cognition

Neuruppin :

A clinical trial seeking patients for a research study for the treatment of Schizophrenia

Pfaffenhofen :

A clinical trial seeking patients for a research study for the treatment of Schizophrenia

Sachsen :

A clinical trial seeking patients for a research study for the treatment of Schizophrenia

Stralsund :

A clinical trial seeking patients for a research study for the treatment of Schizophrenia or Impaired Cognition

Wiesbaden :

A clinical trial seeking patients for a research study for the treatment of Schizophrenia or Impaired Cognition

India

Ahmedabad : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Iloperidone and Placebo for the treatment of Schizophrenia

Ahmedabad : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Iloperidone and Placebo for the treatment of Schizophrenia

Bangalore : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Iloperidone and Placebo for the treatment of Schizophrenia

Chennai : Schizophrenia Research Foundation (SCARF) Mental Health Centre

A clinical trial seeking patients for a research study for the treatment of Tardive Dyskinesia

Hyderabad : Mediciti Hospital

Patients are needed to participate in a clinical research study of Asenapine Sublingual Tablets 10 mg to evaluate Schizophrenia

Jaipur : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Iloperidone and Placebo for the treatment of Schizophrenia

Junagadh : Shri Hatkesh Healthcare Foundation

Patients are needed to participate in a clinical research study of Asenapine Sublingual Tablets 10 mg to evaluate Schizophrenia

Kanpur : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Iloperidone and Placebo for the treatment of Schizophrenia

Kolkata : The Calcutta Medical Research Institute

Patients are needed to participate in a clinical research study of Asenapine Sublingual Tablets 10 mg to evaluate Schizophrenia

Madurai : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Iloperidone and Placebo for the treatment of Schizophrenia

Mangalore : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Iloperidone and Placebo for the treatment of Schizophrenia

Mangalore : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Iloperidone and Placebo for the treatment of Schizophrenia

Manipal : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Iloperidone and Placebo for the treatment of Schizophrenia

Mysore : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Iloperidone and Placebo for the treatment of Schizophrenia

Nashik : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Iloperidone and Placebo for the treatment of Schizophrenia

Pune : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Iloperidone and Placebo for the treatment of Schizophrenia

Surat : Divyam Hospital

Patients are needed to participate in a clinical research study of Asenapine Sublingual Tablets 10 mg to evaluate Schizophrenia

Varanasi : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Iloperidone and Placebo for the treatment of Schizophrenia

Israel

Bat-Yam :

A clinical trial seeking patients for a research study for the treatment of Schizophrenia

Tel Hashomer :

A clinical trial seeking patients for a research study for the treatment of Schizophrenia

Italy

Adrano : Updated

A clinical research study for the treatment of Schizophrenia

Aosta : Updated

A clinical research study for the treatment of Schizophrenia

Bergamo : Updated

A clinical research study for the treatment of Schizophrenia

Brescia : Updated

A clinical research study for the treatment of Schizophrenia

Campobasso : Updated

A clinical research study for the treatment of Schizophrenia

Catania :

A Phase 3 clinical study for patients with Schizophrenia or Impaired Cognition

Chieti : Updated

A clinical research study for the treatment of Schizophrenia

Foggia : Updated

A clinical research study for the treatment of Schizophrenia

Genova : Updated

A clinical research study for the treatment of Schizophrenia

L'Aquila : Updated

A clinical research study for the treatment of Schizophrenia

Legnago : Updated

A clinical research study for the treatment of Schizophrenia

Lido Di Camaiore : Updated

A clinical research study for the treatment of Schizophrenia

Lucca :

A Phase 3 clinical study for patients with Schizophrenia or Impaired Cognition

Milano :

A Phase 3 clinical study for patients with Schizophrenia or Impaired Cognition

Modena : Updated

A clinical research study for the treatment of Schizophrenia

Monza : Updated

A clinical research study for the treatment of Schizophrenia

Novara : Updated

A clinical research study for the treatment of Schizophrenia

Pieve Di Coriano : Updated

A clinical research study for the treatment of Schizophrenia

Pisa : Updated

A clinical research study for the treatment of Schizophrenia

Pisa :

A Phase 3 clinical study for patients with Schizophrenia or Impaired Cognition

Roggiano Gravina : Updated

A clinical research study for the treatment of Schizophrenia

Roma : Updated

A clinical research study for the treatment of Schizophrenia

Roma : Updated

A clinical research study for the treatment of Schizophrenia

Roma : Updated

A clinical research study for the treatment of Schizophrenia

Roma :

A Phase 3 clinical study for patients with Schizophrenia or Impaired Cognition

Salerno : Updated

A clinical research study for the treatment of Schizophrenia

Siena : Updated

A clinical research study for the treatment of Schizophrenia

Solofra : Updated

A clinical research study for the treatment of Schizophrenia

Varese : Updated

A clinical research study for the treatment of Schizophrenia

Japan

Aizuwakamatsu :

Patients are needed to participate in a clinical research study evaluating MP-214 low dose, MP-214 high dose and Risperidone for the treatment of Schizophrenia

Chubu Region :

A clinical research study of Aripiprazole Low (2 mg/day), Aripiprazole Mid (6 - 12 mg/day) and Aripiprazole High (24 - 30 mg/day) for the treatment of Schizophrenia

Chubu Region :

Patients are needed to participate in a clinical research study of Aripiprazole to evaluate Schizophrenia

Chugoku Region :

A clinical research study of Aripiprazole Low (2 mg/day), Aripiprazole Mid (6 - 12 mg/day) and Aripiprazole High (24 - 30 mg/day) for the treatment of Schizophrenia

Chugoku Region :

Patients are needed to participate in a clinical research study of Aripiprazole to evaluate Schizophrenia

Hokkaido Region :

A clinical research study of Aripiprazole Low (2 mg/day), Aripiprazole Mid (6 - 12 mg/day) and Aripiprazole High (24 - 30 mg/day) for the treatment of Schizophrenia

Hokkaido Region :

Patients are needed to participate in a clinical research study of Aripiprazole to evaluate Schizophrenia

Kansai Region :

A clinical research study of Aripiprazole Low (2 mg/day), Aripiprazole Mid (6 - 12 mg/day) and Aripiprazole High (24 - 30 mg/day) for the treatment of Schizophrenia

Kansai Region :

Patients are needed to participate in a clinical research study of Aripiprazole to evaluate Schizophrenia

Kanto Region :

A clinical research study of Aripiprazole Low (2 mg/day), Aripiprazole Mid (6 - 12 mg/day) and Aripiprazole High (24 - 30 mg/day) for the treatment of Schizophrenia

Kanto Region :

A clinical trial seeking patients for a research study for the treatment of Schizophrenia

Kanto Region :

A clinical trial to evaluate treatments using OPC-34712 for patients with Schizophrenia

Kanto Region :

Patients are needed to participate in a clinical research study of Aripiprazole to evaluate Schizophrenia

Kyushu Region :

A clinical research study of Aripiprazole Low (2 mg/day), Aripiprazole Mid (6 - 12 mg/day) and Aripiprazole High (24 - 30 mg/day) for the treatment of Schizophrenia

Kyushu Region :

Patients are needed to participate in a clinical research study of Aripiprazole to evaluate Schizophrenia

Sapporo :

A clinical trial seeking patients for a research study for the treatment of Schizophrenia

Sapporo :

Patients are needed to participate in a clinical research study to evaluate Schizophrenia

Shikoku Region :

A clinical research study of Aripiprazole Low (2 mg/day), Aripiprazole Mid (6 - 12 mg/day) and Aripiprazole High (24 - 30 mg/day) for the treatment of Schizophrenia

Shikoku Region :

Patients are needed to participate in a clinical research study of Aripiprazole to evaluate Schizophrenia

Tohoku Region :

A clinical research study of Aripiprazole Low (2 mg/day), Aripiprazole Mid (6 - 12 mg/day) and Aripiprazole High (24 - 30 mg/day) for the treatment of Schizophrenia

Tohoku Region :

Patients are needed to participate in a clinical research study of Aripiprazole to evaluate Schizophrenia

Tokyo, etc : 55 Sites

Patients are needed to participate in a clinical research study evaluating SM-13496 for the treatment of Schizophrenia

Tokyo, etc : 55 Sites

Patients are needed to participate in a clinical research study of SM-13496 40mg, SM-13496 80mg and Placebo to evaluate Schizophrenia

Korea, Republic of

Ansan : Korea University Medical Center Ansan Hospital

Patients are needed to participate in a clinical research study evaluating Ziprasidone for the treatment of Schizophrenia or Schizoaffective Disorder

Bucheon : Soonchunhyang University Bucheon Hospital

Patients are needed to participate in a clinical research study evaluating Ziprasidone for the treatment of Schizophrenia or Schizoaffective Disorder

Goyang-si : Dongguk University International Hospital

Patients are needed to participate in a clinical research study of paliperidone to evaluate Schizophrenia

Incheon : Catholic University Our Lady of Mercy Hospital

Patients are needed to participate in a clinical research study evaluating Ziprasidone for the treatment of Schizophrenia or Schizoaffective Disorder

Incheon : Inha University Hospital

Patients are needed to participate in a clinical research study evaluating Ziprasidone for the treatment of Schizophrenia or Schizoaffective Disorder

Kyungki : Updated

Patients are needed to participate in a clinical research study to evaluate Schizophrenia

Seoul : Seoul National University Hospital

A clinical research study of Metformin and Placebo (for metformin) for the treatment of Schizophrenia

Seoul :

A clinical trial seeking patients for a research study for the treatment of Schizophrenia

Seoul : Korea University Medical Center Guro Hospital

Patients are needed to participate in a clinical research study evaluating Ziprasidone for the treatment of Schizophrenia or Schizoaffective Disorder

Seoul : Kangnam Sacred Heart Hospital

Patients are needed to participate in a clinical research study evaluating Ziprasidone for the treatment of Schizophrenia or Schizoaffective Disorder

Seoul : Seoul National University Hospital

Patients are needed to participate in a clinical research study of paliperidone to evaluate Schizophrenia

Seoul : Seoul National Hospital

Patients are needed to participate in a clinical research study to evaluate Metabolic Syndrome or Schizophrenia

Seoul :

Patients are needed to participate in a clinical research study to evaluate Schizophrenia

Seoul : Seoul National Hospital

Patients are needed to participate in a clinical research study to evaluate Schizophrenia or Metabolic Syndrome

Seoul : Seoul National Hospital

Patients are needed to participate in a clinical research study to evaluate Schizophrenia or Metabolic Syndrome

Seoul, etc : 14 Sites

Patients are needed to participate in a clinical research study evaluating SM-13496 for the treatment of Schizophrenia

Seoul, etc : 14 Sites

Patients are needed to participate in a clinical research study of SM-13496 40mg, SM-13496 80mg and Placebo to evaluate Schizophrenia

Malaysia

Cheras : Alkermes Investigational Site

Patients are needed to participate in a clinical research study evaluating ALKS 9072, Low and ALKS 9072, High for the treatment of Schizophrenia

Ipoh : Research Site

20110165: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms

Ipoh : Research Site

20110165: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms

Johor Bahru : Alkermes Investigational Site

Patients are needed to participate in a clinical research study evaluating ALKS 9072, Low and ALKS 9072, High for the treatment of Schizophrenia

Kajang :

A clinical trial to evaluate treatments using Brexpiprazole and Placebo for patients with Acute Schizophrenia

Kota Bahru :

A clinical trial to evaluate treatments using Brexpiprazole and Placebo for patients with Acute Schizophrenia

Kuala Lumpur : Research Site

20110165: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms

Kuala Lumpur : Research Site

20110165: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms

Kuala Lumpur : Research Site

20110165: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms

Kuala Lumpur :

A clinical trial to evaluate treatments using Brexpiprazole and Placebo for patients with Acute Schizophrenia

Kuala Lumpur : Alkermes Investigational Site

Patients are needed to participate in a clinical research study evaluating ALKS 9072, Low and ALKS 9072, High for the treatment of Schizophrenia

Kuching : Alkermes Investigational Site

Patients are needed to participate in a clinical research study evaluating ALKS 9072, Low and ALKS 9072, High for the treatment of Schizophrenia

Sabah :

A clinical trial to evaluate treatments using Brexpiprazole and Placebo for patients with Acute Schizophrenia

New Zealand

Takapuna, Auckland : Research Site

20101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms

Philippines

Mandaluyong City : Alkermes Investigational Site

Patients are needed to participate in a clinical research study evaluating ALKS 9072, Low and ALKS 9072, High for the treatment of Schizophrenia

Poland

Bydgoszcz : Research Site

20110165: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms

Chelmno : Research Site

20110165: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms

Katowice : Research Site

20110165: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms

Skorzewo : Research Site

20110165: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms

Torun : Research Site

20110165: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms

Zuromin : Research Site

20110165: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms

Puerto Rico

Caguas : Centro de Investigacion Clinica Psiquiatrica

Patients are needed to participate in a clinical research study to evaluate Schizophrenia

Ponce : Centro de Investigacion Clinica Psiquiatrica

Patients are needed to participate in a clinical research study to evaluate Schizophrenia

San Juan :

A clinical trial to evaluate treatments using Brexpiprazole and Placebo for patients with Acute Schizophrenia

San Juan :

A clinical trial to evaluate treatments using Brexpiprazole and Placebo for patients with Acute Schizophrenia

San Juan : INSPIRA Clinical Research

Patients are needed to participate in a clinical research study to evaluate Schizophrenia

Romania

Arad :

A clinical trial to evaluate treatments using Brexpiprazole and Placebo for patients with Acute Schizophrenia

Brasov :

A clinical trial to evaluate treatments using Brexpiprazole and Placebo for patients with Acute Schizophrenia

Bucharest : Merck Sharp & Dohme Romania SRL

A clinical trial to evaluate treatments using Asenapine, Placebo Asenapine, Olanzapine and Placebo Olanzapine for patients with Schizophrenia

Bucuresti : Spitalul de Psihiatrie Titan "Dr Constantin Gorgos"

A clinical trial seeking patients for a research study for the treatment of Schizophrenia

Bucuresti : Spitalul Clinic de Psihiatrie Prof. Dr. Alexandru Obregia

A clinical trial seeking patients for a research study for the treatment of Schizophrenia

Bucuresti : Spitalul Universitar de Urgenta Militar Central "Dr Carol Davila"

A clinical trial seeking patients for a research study for the treatment of Schizophrenia

Bucuresti :

A clinical trial to evaluate treatments using Brexpiprazole and Placebo for patients with Acute Schizophrenia

Bucuresti :

A Phase 3 clinical study for patients with Schizophrenia or Impaired Cognition

Campulung :

A Phase 3 clinical study for patients with Schizophrenia or Impaired Cognition

Craiova : Spitalul Clinic de Neuropsihiatrie Craiova

A clinical trial seeking patients for a research study for the treatment of Schizophrenia

Craiova :

A clinical trial to evaluate treatments using Brexpiprazole and Placebo for patients with Acute Schizophrenia

Focsani : Spitalul Judetean de Urgenta "Sf. Pantelimon" Focsani

A clinical trial seeking patients for a research study for the treatment of Schizophrenia

Focsani :

A clinical trial to evaluate treatments using Brexpiprazole and Placebo for patients with Acute Schizophrenia

Galati : Spitalul de Psihiatrie "Elisabeta Doamna"

A clinical trial seeking patients for a research study for the treatment of Schizophrenia

Iasi : Spitalul Clinic de Psihiatrie Socola

A clinical trial seeking patients for a research study for the treatment of Schizophrenia

Iasi :

A clinical trial to evaluate treatments using Brexpiprazole and Placebo for patients with Acute Schizophrenia

Iasi :

A Phase 3 clinical study for patients with Schizophrenia or Impaired Cognition

Pitesti : Spitalul Judetean de Urgenta Pitesti

A clinical trial seeking patients for a research study for the treatment of Schizophrenia

Pitesti :

A clinical trial to evaluate treatments using Brexpiprazole and Placebo for patients with Acute Schizophrenia

Targoviste : Spitalul Judetean de Urgenta Targoviste

A clinical trial seeking patients for a research study for the treatment of Schizophrenia

Targoviste :

A clinical trial to evaluate treatments using Brexpiprazole and Placebo for patients with Acute Schizophrenia

Targu-Mures :

A Phase 3 clinical study for patients with Schizophrenia or Impaired Cognition

Russian Federation

Arkhangelsk : SHI Arkhangelsk Regional Clinical Psychiatric Hospital

A clinical trial seeking patients for a research study for the treatment of Schizophrenia

Chelyabinsk :

A clinical trial seeking patients for a research study for the treatment of Schizophrenia

Chelyabinsk : SHI Reg Clinical Specialized Psychoneurological Hospital #1

A clinical trial seeking patients for a research study for the treatment of Schizophrenia

Kemerovo : Kemerovo Regional Clinical Psychiatric Hospital

A clinical trial seeking patients for a research study for the treatment of Schizophrenia

Khotkovo : Research Site

20101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms

Lipetsk : Updated

A clinical research study for the treatment of Schizophrenia

Lipetsk region : GUZ Lipetsk Regional psychoneurological Hospital #1

A clinical trial seeking patients for a research study for the treatment of Schizophrenia

Moscow : Research Site

20101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms

Moscow : Research Site

20101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms

Moscow : Updated

A clinical research study for the treatment of Schizophrenia

Moscow : Updated

A clinical research study for the treatment of Schizophrenia

Moscow : Updated

A clinical research study for the treatment of Schizophrenia

Moscow :

A clinical trial seeking patients for a research study for the treatment of Schizophrenia or Impaired Cognition

Moscow : Merck Sharp & Dohme IDEA, Inc.

A clinical trial to evaluate treatments using Asenapine, Placebo Asenapine, Olanzapine and Placebo Olanzapine for patients with Schizophrenia

Moscow :

A Phase 3 clinical study for patients with Schizophrenia or Impaired Cognition

Moscow : Alkermes Investigational Site

Patients are needed to participate in a clinical research study evaluating ALKS 9072, Low and ALKS 9072, High for the treatment of Schizophrenia

Moscow Region : Updated

A clinical research study for the treatment of Schizophrenia

Moscow Region : Moscow Region Psychiatric Hospital #5

A clinical trial seeking patients for a research study for the treatment of Schizophrenia

Nizhniy Novgorod :

A clinical trial seeking patients for a research study for the treatment of Schizophrenia

Nizhny Novgorod : Updated

A clinical research study for the treatment of Schizophrenia

Saint- Petersburg : Research Site

20101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms

Saint-Petersburg :

A clinical trial seeking patients for a research study for the treatment of Schizophrenia or Impaired Cognition

Saint-Petersburg :

A Phase 3 clinical study for patients with Schizophrenia or Impaired Cognition

Saint-Petersburg :

A Phase 3 clinical study for patients with Schizophrenia or Impaired Cognition

Samara : SBHI "Samara Psychiatric Clinic"

A clinical trial seeking patients for a research study for the treatment of Schizophrenia

Samara :

A Phase 3 clinical study for patients with Schizophrenia or Impaired Cognition

Saratov : Research Site

20101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms

Saratov : MHI City Clinical Hospital #2 named after V.I. Razumovsky

A clinical trial seeking patients for a research study for the treatment of Schizophrenia

Smolensk :

A Phase 3 clinical study for patients with Schizophrenia or Impaired Cognition

St Petersburg : Updated

A clinical research study for the treatment of Schizophrenia

St Petersburg : Updated

A clinical research study for the treatment of Schizophrenia

St Petersburg : FSBI "Bekhterev Psychoneurological Research Institute SPb Russia"

A clinical trial seeking patients for a research study for the treatment of Schizophrenia

St. Petersburg : City Psychiatric Hospital #4

A clinical trial seeking patients for a research study for the treatment of Schizophrenia

St. Petersburg : City Psychiatric Hospital of St. Nikolay Chudotvorets

A clinical trial seeking patients for a research study for the treatment of Schizophrenia

St. Petersburg : SPHI "City Mental Hospital #3 n.a. I.I.Skvortsov-Stepanov"

A clinical trial seeking patients for a research study for the treatment of Schizophrenia

St. Petersburg : Alkermes Investigational Site

Patients are needed to participate in a clinical research study evaluating ALKS 9072, Low and ALKS 9072, High for the treatment of Schizophrenia

Stavropol :

A clinical trial seeking patients for a research study for the treatment of Schizophrenia or Impaired Cognition

Talagi :

A clinical trial seeking patients for a research study for the treatment of Schizophrenia or Impaired Cognition

Talagi : Alkermes Investigational Site

Patients are needed to participate in a clinical research study evaluating ALKS 9072, Low and ALKS 9072, High for the treatment of Schizophrenia

Tomsk : FSBI "Research Institute for Mental Health" of Siberian branch of RAMS

A clinical trial seeking patients for a research study for the treatment of Schizophrenia

Yaroslavl :

A clinical trial seeking patients for a research study for the treatment of Schizophrenia

Yaroslavl :

A Phase 3 clinical study for patients with Schizophrenia or Impaired Cognition

Serbia

Belgrade :

A clinical trial to evaluate treatments using Brexpiprazole and Placebo for patients with Acute Schizophrenia

Kragujevac :

A clinical trial to evaluate treatments using Brexpiprazole and Placebo for patients with Acute Schizophrenia

Novi Knezevac :

A clinical trial to evaluate treatments using Brexpiprazole and Placebo for patients with Acute Schizophrenia

Novi Sad :

A clinical trial to evaluate treatments using Brexpiprazole and Placebo for patients with Acute Schizophrenia

Singapore

Singapore : Research Site

20101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms

Singapore :

A clinical trial seeking patients for a research study for the treatment of Schizophrenia or Impaired Cognition

Slovakia

Bojnice : Nemocnica s poliklinikou Prievidza so sidlom v Bojniciach

A clinical trial seeking patients for a research study for the treatment of Schizophrenia

Brastislava : Univerzitna nemocnica Bratislava, Nemocnica Ruzinov

A clinical trial seeking patients for a research study for the treatment of Schizophrenia

Hronovce : Psychiatricka nemocnica Hronovce

A clinical trial seeking patients for a research study for the treatment of Schizophrenia

Michalovce : Psychiatricka nemocnica Michalovce, n.o.

A clinical trial seeking patients for a research study for the treatment of Schizophrenia

Rimavska Sobota : Vseobecna nemocnica Rimavska Sobota

A clinical trial seeking patients for a research study for the treatment of Schizophrenia

Roznava : Nemocnica s poliklinikou sv. Barbory Roznava a.s.

A clinical trial seeking patients for a research study for the treatment of Schizophrenia

Spain

Alcorcon :

A clinical trial seeking patients for a research study for the treatment of Schizophrenia or Impaired Cognition

Barcelona : Research Site

20101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms

Cornellá de Llobregat : Research Site

20101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms

Coslada :

A clinical trial seeking patients for a research study for the treatment of Schizophrenia or Impaired Cognition

L'Hospitalet de Llobregat : Research Site

20101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms

Madrid : Research Site

20101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms

Madrid :

A clinical trial seeking patients for a research study for the treatment of Schizophrenia or Impaired Cognition

Mataro :

A clinical trial seeking patients for a research study for the treatment of Schizophrenia or Impaired Cognition

Salamanca :

A clinical trial seeking patients for a research study for the treatment of Schizophrenia or Impaired Cognition

Santander : Research Site

20101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms

Valencia : Research Site

20101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms

Zamora :

A clinical trial seeking patients for a research study for the treatment of Schizophrenia or Impaired Cognition

Taiwan

Bali Township, Taipei County :

A clinical research study of Paliperidone extended-release and Risperidone immediate-release for the treatment of Schizophrenia

Hua Lian :

A clinical research study of Paliperidone extended-release and Risperidone immediate-release for the treatment of Schizophrenia

Kaohsiung :

A clinical research study of Paliperidone extended-release and Risperidone immediate-release for the treatment of Schizophrenia

Taipei :

A clinical trial seeking patients for a research study for the treatment of Schizophrenia

Taipei :

Patients are needed to participate in a clinical research study to evaluate Schizophrenia

Taipei, etc : 12Sites

Patients are needed to participate in a clinical research study evaluating SM-13496 for the treatment of Schizophrenia

Taipei, etc : 12 Sites

Patients are needed to participate in a clinical research study of SM-13496 40mg, SM-13496 80mg and Placebo to evaluate Schizophrenia

Turkey

?stanbul : Updated

A clinical research study for the treatment of Schizophrenia

Ankara : Updated

A clinical research study for the treatment of Schizophrenia

Diyarbakir : Updated

A clinical research study for the treatment of Schizophrenia

Gaziantep : Updated

A clinical research study for the treatment of Schizophrenia

Istanbul : Updated

A clinical research study for the treatment of Schizophrenia

Kocaeli : Updated

A clinical research study for the treatment of Schizophrenia

Manisa : Updated

A clinical research study for the treatment of Schizophrenia

Mersin : Updated

A clinical research study for the treatment of Schizophrenia

Samsun : Updated

A clinical research study for the treatment of Schizophrenia

Ukraine

Chernigiv : Alkermes Investigational Site

Patients are needed to participate in a clinical research study evaluating ALKS 9072, Low and ALKS 9072, High for the treatment of Schizophrenia

Chernigiv district, Chernigiv : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Iloperidone and Placebo for the treatment of Schizophrenia

Dnipropetrovsk :

A Phase 3 clinical study for patients with Schizophrenia or Impaired Cognition

Dnipropetrovsk : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Iloperidone and Placebo for the treatment of Schizophrenia

Dnipropetrovsk : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Iloperidone and Placebo for the treatment of Schizophrenia

Donetsk : Donetsk M. Gorkyi NMU Ch of Psychiatry, Narcology and MP CT&PI RCPsH

A clinical trial seeking patients for a research study for the treatment of Schizophrenia

Donetsk :

A clinical trial seeking patients for a research study for the treatment of Schizophrenia or Impaired Cognition

Donetsk : Alkermes Investigational Site

Patients are needed to participate in a clinical research study evaluating ALKS 9072, Low and ALKS 9072, High for the treatment of Schizophrenia

Donezk : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Iloperidone and Placebo for the treatment of Schizophrenia

Ivano-Frankivsk : Regional Psychoneurological Hospital #3

A clinical trial seeking patients for a research study for the treatment of Schizophrenia

Ivano-Frankivsk :

A clinical trial seeking patients for a research study for the treatment of Schizophrenia or Impaired Cognition

Kerch, AR Crimea : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Iloperidone and Placebo for the treatment of Schizophrenia

Kharkiv : SMPI Central Clinical Hospital of Ukrzaliznytsia

A clinical trial seeking patients for a research study for the treatment of Schizophrenia

Kharkiv :

A clinical trial seeking patients for a research study for the treatment of Schizophrenia or Impaired Cognition

Kharkiv :

A clinical trial to evaluate treatments using Brexpiprazole and Placebo for patients with Acute Schizophrenia

Kharkiv :

A clinical trial to evaluate treatments using Brexpiprazole and Placebo for patients with Acute Schizophrenia

Kharkiv :

A Phase 3 clinical study for patients with Schizophrenia or Impaired Cognition

Kharkiv : Alkermes Investigational Site

Patients are needed to participate in a clinical research study evaluating ALKS 9072, Low and ALKS 9072, High for the treatment of Schizophrenia

Kharkiv : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Iloperidone and Placebo for the treatment of Schizophrenia

Kherson Vil. Stepanivka : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Iloperidone and Placebo for the treatment of Schizophrenia

Kherson,Vil. Stepanivka : CI Kherson Regional Psychiatric Hospital of Kherson RC

A clinical trial seeking patients for a research study for the treatment of Schizophrenia

Kiev : MSD Ukraine LLC

A clinical trial to evaluate treatments using Asenapine, Placebo Asenapine, Olanzapine and Placebo Olanzapine for patients with Schizophrenia

Kiev : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Iloperidone and Placebo for the treatment of Schizophrenia

Kiev : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Iloperidone and Placebo for the treatment of Schizophrenia

Kyiv : Kyiv City Clinical Psychoneurological Hospital #1

A clinical trial seeking patients for a research study for the treatment of Schizophrenia

Kyiv :

A clinical trial seeking patients for a research study for the treatment of Schizophrenia or Impaired Cognition

Kyiv :

A clinical trial to evaluate treatments using Brexpiprazole and Placebo for patients with Acute Schizophrenia

Kyiv :

A Phase 3 clinical study for patients with Schizophrenia or Impaired Cognition

Kyiv : Alkermes Investigational Site

Patients are needed to participate in a clinical research study evaluating ALKS 9072, Low and ALKS 9072, High for the treatment of Schizophrenia

Kyiv : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Iloperidone and Placebo for the treatment of Schizophrenia

Kyiv region, Glevakha : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Iloperidone and Placebo for the treatment of Schizophrenia

Lugansk :

A clinical trial seeking patients for a research study for the treatment of Schizophrenia or Impaired Cognition

Lugansk : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Iloperidone and Placebo for the treatment of Schizophrenia

Lviv :

A clinical trial to evaluate treatments using Brexpiprazole and Placebo for patients with Acute Schizophrenia

Lviv :

A Phase 3 clinical study for patients with Schizophrenia or Impaired Cognition

Odesa : Odesa Regional Psychoneurogical Dispensary

A clinical trial seeking patients for a research study for the treatment of Schizophrenia

Odesa :

A clinical trial to evaluate treatments using Brexpiprazole and Placebo for patients with Acute Schizophrenia

Odesa : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Iloperidone and Placebo for the treatment of Schizophrenia

Poltava :

A Phase 3 clinical study for patients with Schizophrenia or Impaired Cognition

Poltava : Alkermes Investigational Site

Patients are needed to participate in a clinical research study evaluating ALKS 9072, Low and ALKS 9072, High for the treatment of Schizophrenia

Poltava : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Iloperidone and Placebo for the treatment of Schizophrenia

Simferopol : SI S.I. Heorhievskyi CSMU Ch of PPN with the Course of G&MP CRI CPH #1

A clinical trial seeking patients for a research study for the treatment of Schizophrenia

Simferopol : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Iloperidone and Placebo for the treatment of Schizophrenia

Stepanovka : Alkermes Investigational Site

Patients are needed to participate in a clinical research study evaluating ALKS 9072, Low and ALKS 9072, High for the treatment of Schizophrenia

Ternopil : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Iloperidone and Placebo for the treatment of Schizophrenia

vil. Stepanivka :

A Phase 3 clinical study for patients with Schizophrenia or Impaired Cognition

Vinnytsia : M.I. Pyrogov VNMU Ch of Psych&Nar BO CI O.I. Yuschenko VRPsH

A clinical trial seeking patients for a research study for the treatment of Schizophrenia

Vinnytsia :

A Phase 3 clinical study for patients with Schizophrenia or Impaired Cognition

Vinnytsia : Alkermes Investigational Site

Patients are needed to participate in a clinical research study evaluating ALKS 9072, Low and ALKS 9072, High for the treatment of Schizophrenia

Vinnytsya : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Iloperidone and Placebo for the treatment of Schizophrenia

Yevpatoriya : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Iloperidone and Placebo for the treatment of Schizophrenia

United Kingdom

Barnet : Research Site

20110165: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms

Cambridge :

A Phase 3 clinical study for patients with Schizophrenia or Impaired Cognition

Edinburgh : Research Site

20110165: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms

Headington : Department of Psychiatry, University of Oxford, Warneford Hospital Updated

A clinical trial seeking patients for a research study for the treatment of Schizophrenia

Hemel Hempstead : Updated

A clinical research study for the treatment of Schizophrenia

London : Research Site

20110165: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms

London :

A Phase 3 clinical study for patients with Schizophrenia or Impaired Cognition

Manchester : University of Manchester, Neuroscience and Psychiatry Unit Updated

A clinical trial seeking patients for a research study for the treatment of Schizophrenia

Norwich : Research Site

20110165: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms

Sheffield : Research Site

20110165: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms

Warrington : Research Site

20110165: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms

 

 

 

QUICK FIND LIST

ABOUT NFA

Programs

Our History

Medical Advisory

Board

 

ARTICLES

English

Spanish

 

STORE

Jewelry

Education

Awareness Items

Goodies

Apparel

FIBROMYALGIA

What is Fibromyalgia?

Who is Affected?

What are the Symptoms?

How is Fibromyalgia Diagnosed?

What Causes Fibromyalgia?

Science of Fibromyalgia

How is Fibromyalgia Treated?

What is the Prognosis?

An Overview for the Newly Diagnosed Patient

 

RESEARCH

Abstracts

Clinical Trials

Research Overview

COMMUNITY

Support Group Information

FM Community Events

Leaders Against Pain

Advocacy

Awareness Day

Membership

Member Spotlight

Patient Stories

 

MEDIA

Fact Sheets

Press Releases

RESOURCES

Resource Directory

Glossary of Terms and Definitions

Sponsors

Featured Advertisers

AWARE Magazine

FM Online Newsletter

 

We're On Facebook

 

 

Home | Privacy Policy | General Policy | Change Your Password/Update Your Profile | http://www.fmaware.org/